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Abstract 
The desensitized state of neurotransmitter-gated ion channels (NGICs) remains poorly understand, both 
in terms of its functional role and its structure. Although the state was historically thought to have 
limited functional relevance, recent results have demonstrated that the state is indeed likely to play a 
role in shaping receptor responses to normal physiological stimulation. To determine the generality of 
this role, we subjected all types of NGICs known to exist in the human body to high-frequency 
stimulation and quantified the impact of the desensitized state on their responses. Our results, 
presented in Chapter II, show that the desensitized state is likely to be visited by all of these receptors in 
response to synaptic-like stimulation. Furthermore, our findings indicate that the desensitized state can 
enable receptors to act as low-pass filters, a behavior that had been observed to occur in synapses, but 
which had not been attributed to receptors. In Chapter III, we investigate the unusual desensitization 
properties of the α3β4 AChRs, receptors that are the primary mediators of fast-synaptic transmission in 
the autonomic ganglia. Previously, it had been proposed that oxidation of an intracellular cysteine is 
fundamentally critical in the mechanism of this unusual desensitization; in the work presented in 
Chapter III, we found that this cysteine oxidation hypothesis cannot explain our results, implying that 
the mechanism must be more complex than was previously proposed. In the work presented in Chapter 
IV, we used scanning mutagenesis to investigate whether the M1-M2 linker of pentameric ligand-gated 
ion channels is likely to undergo structural rearrangement during open-closed and open-desensitized 
transitions. We found that this region is unlikely to be important during these kinetic transitions, 
implying that the hinge point to accommodate the tilting of the pore-lining M2 helix is likely to be near 
the intracellular edge of the pore. We also investigated the structure-function relationship underlying 
the variability in desensitization kinetics and found that, at least in glycine receptors, post-translational 
modification of the M3-M4 loop cannot account for the large variability in behavior seen from cell to 
cell. Overall, the results presented in this dissertation shine light on the functional role of the 
desensitized state and give novel insight into the structure and regulation of this conformation. 
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Thesis outline 
The experimental work presented in this document is divided into three sections: (1) an experimental 
investigation into the physiological relevance of the desensitization of neurotransmitter-gated ion 
channels (NGICs); (2) an attempt to determine the mechanism underlying the irreversible 
desensitization of α3β4 AChRs in outside-out patches; and (3) an investigation into the role of the M1-
M2 loop in conformational changes associated with channel gating and desensitization. Accordingly, the 
results of this document are divided into three chapters (Chapters II, III, and IV). In Chapter I, relevant 
background information is presented, to give better context for the results in Chapters II-IV. 
Chapter II is largely reproduced from Papke et al., 2011. I am in the process of combining Chapters III 
and IV to generate a manuscript for submission to a peer-reviewed journal. As an appendix, I have 
included a piece written for Physiology News (Papke and Grosman, in press). The latter work is intended 
to be a mini-review aimed at a broad audience, contextualizing the work presented in Chapter II. 
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Chapter I – Background Information 
1.1  Known types of ligand-gated ionotropic receptors and their classifications 
There are three major superfamilies of NGICs: the pLGIC superfamily, the excitatory glutamate receptor 
superfamily, and the purinergic receptor superfamily. All superfamilies have members known to be 
involved in fast synaptic transmission, although some receptors from each superfamily have other 
functions as well. The primary functional similarity among all receptors is that they all can occupy open, 
closed and desensitized states, and that they all respond to externally applied neurotransmitter. 
However, there are some major structural differences across the superfamilies: pLGIC family members 
are composed of five subunits, excitatory glutamate family members are composed of four, and 
purinergic family members are composed of three. At this point, there are X-ray crystallographic 
structures for members of each family, which have largely confirmed structural models derived from 
experimental probing of the channels. Unfortunately, because it is difficult to assign functional states to 
the structures (Gonzalez-Gutierrez et al., 2012), there is still uncertainty regarding the structure of the 
experimentally observed functional states in some cases. Furthermore, the conformational changes 
associated with gating and desensitization are an open topic for pLGICs and P2XRs. In Chapter IV, we 
present our own experimental work in which we examine the role of a particular linker in the 
conformational changes associated with gating and desensitization in pLGICs. 
1.1.1  Pentameric ligand-gated ion channel superfamily 
1.1.1.1  Structure 
Pentameric ligand-gated ion channels (pLGICs) are also known as Cys-loop receptors because, until 
recently, all known members of the family contained an extracellular loop formed by a disulfide bridge 
between cysteines. However, with the discovery of bacterial family members that lack this feature 
(Tasneem et al., 2005; Rendon et al., 2011), the term pLGIC has been gaining traction.  
pLGICs are pentameric receptor-channels that contain multiple extracellular binding sites, a 
transmembrane pore lined by five α-helices (one contributed by each subunit), and an intracellular 
domain that is highly variable across receptors (Figure 1.1). Binding sites are located in the extracellular 
domain at the interfaces between subunits. Members of the pLGIC superfamily have between two and 
five binding sites, depending on the specific receptor and its subunit composition. The transmembrane 
domain of each pLGIC subunit contains four membrane-spanning α-helices, named M1-M4. These 
helices are arranged such that M2 is pore lining, M1 and M3 are behind M2 (relative to the pore) and 
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are roughly equidistant from the pore, and M4 is located behind M1 and M3. The intracellular domain is 
the most variable region across family members – bacterial channels only have short linkers (Tasneem et 
al., 2005; Rendon et al., 2011), while vertebrate and invertebrate pLGICs have a large cytosolic loop that 
contains many sites for interactions with cytosolic proteins, as we will expand upon in Sections 1.2 and 
1.3.  
 
Basic structural elements of the transmembrane region had been elucidated prior to the determination 
of X-ray crystallographic structures (for example, affinity labeling was used to confirm the α-helical 
nature of M2 in Giraudat et al., 1986). Cryo-electron microscopy (cryo-EM) confirmed many hypotheses 
about the structure of the extracellular and transmembrane domains (Miyazawa et al., 2003; Unwin, 
2005), and these results were further verified by X-ray crystallographic structures of recently discovered 
bacterial family members (Tasneem et al., 2005; Hilf and Dutzler, 2008; Hilf and Dutzler, 2009; Bocquet 
et al., 2009) and, more recently, an invertebrate pLGIC (Hibbs and Gouaux, 2011). The structure of the 
open state of a Cys-loop receptor has also been probed through mutagenesis and electrophysiological 
Figure 1.1. The architecture of pLGICs. Images were 
generated from 2BG9, the cryo-EM Torpedo AChR 
model of the closed state (Unwin, 2005), using VMD 
(Humphrey et al., 1996). A, A view from the 
extracellular domain. Xs mark the AChR binding sites. 
B, A side view, where the lines demarcate the 
approximate location of the membrane. 
 3 
 
recording, leading to the conclusion that the cryo-EM closed state must be structurally similar to the 
open state (Cymes et al., 2005; Cymes and Grosman, 2008). Unfortunately, although open and closed 
structures have been proposed based on X-ray crystallography data (Hilf and Dutzler 2009; Bocquet et 
al., 2009), it is not clear whether these structures correspond to their assigned functional states 
(Gonzalez-Gutierrez and Grosman, 2010; Parikh et al., 2011). 
1.1.1.2  Physiological function 
Members of the pLGIC superfamily include the GABAARs, GlyRs and AChRs in vertebrates. The GABAARs 
and GlyRs are the primary mediators of fast inhibitory synaptic transmission in the central nervous 
system. GlyRs are involved in spinal reflexes (Floeter et al., 1996), and mutations to GlyRs can cause 
hyperekplexia, a rare neurological disorder characterized by an excessive startle response. GlyRs and 
GABAARs are known to be targets of many drugs, including anesthetics and alcohol (Mihic et al., 1997).  
There are many subtypes of AChRs, all of which are excitatory, cation-selective channels. Despite strong 
sequence identity, these subtypes exhibit a wide range of behavior. Muscle-type AChRs (comprised of 
α1, β1, δ and γ (fetal) or ε (adult) subunits) are the primary mediators of fast-synaptic transmission in 
the peripheral nervous system, located in the well-studied neuromuscular junction. Neuronal AChRs are 
composed of many different combinations of the remaining α subunits (α2-α9) and β subunits (β2-β4) 
not found in the muscle AChR. Unfortunately, these receptors are less amenable to rigorous kinetic 
characterization than the muscle AChR. Most of the neuronal AChRs express poorly in heterologous 
systems, making it difficult to achieve patches with many channels (extensive work has been done to 
optimize expression; see Aztiria et al., 2000). As a result of these expression problems, for most receptor 
subtypes, only coarse, qualitative data, such as EC50 values measured in two-electrode voltage clamping 
setups (Papke et al., 2007), are available. For the few subtypes that express well, a striking 
heterogeneity in behavior has been observed, making it difficult to quantify receptor behavior (Lewis et 
al., 1997).  
Neuronal nicotinic receptors have been implicated in the pathophysiology of many diseases, including 
Alzheimer’s disease (Sugaya et al., 1990; Dziewczapolski et al., 2009), diabetic neuropathy (Campanucci 
et al., 2008), schizophrenia (Guan et al., 1999; Perl et al., 2003), and a particular type of congenital 
epilepsy (Steinlein et al., 1995); they are also at the heart of the neurophysiology of nicotine addiction 
(Kuryatov et al., 2011). Until we gain better insight into the kinetic behavior of the neuronal nicotinic 
receptors, it will remain difficult to understand their function in these medically important phenomena. 
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1.1.2  Excitatory glutamate-gated ion channel superfamily 
1.1.2.1  Structure 
The excitatory glutamate-gated receptor superfamily includes AMPA-type glutamate receptors, NMDA-
type glutamate receptors (NMDARs), and kainate-type glutamate receptors. All of these receptors are 
involved in fast-synaptic transmission in the central nervous system. Of the three types of excitatory 
glutamate receptors, the AMPARs are the best understood, both in terms of their physiological role and 
the relationship between their structure and function. For this reason, we will focus on the AMPARs in 
this discussion and, later, in Chapter II. 
 
Figure 1.2. The architecture of excitatory glutamate receptors. Images were generated from 3KG2, the 
rat GluA2 AMPAR closed state model (Sobolevsky et al., 2009), using VMD (Humphrey et al., 1996). A, A 
view from the extracellular domain. Red and blue subunits interact to form a dimer, as do grey and gold 
subunits. Xs mark the glutamate binding sites. B, A side view. Grey lines indicate the approximate 
location of the membrane, the green region contains the ligand binding domain, and the purple region 
contains the amino-terminal domain. 
 
AMPARs are tetrameric ion channels that are composed of different combinations of GluA1-GluA4 
subunits. There has been a wealth of X-ray crystallographic data published on these receptors, with 
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structures unequivocally depicting the protein in various states. Some of the first published structures 
showed the binding domain in the closed, unliganded state, as well as bound to agonists and antagonists 
(Armstrong and Gouaux, 2000). Structures also appeared showing the extracellular domain in the 
desensitized conformation (Sun et al., 2002) and, eventually, showing the entire protein bound to 
antagonist (Sobolevsky et al., 2009). An interesting feature borne out by these structures is that the 
receptors show a functional two-fold axis of symmetry, with pairs of subunits coming together to form 
dimers (Figure 1.2). The structure of the desensitized state clearly shows that the intradimer interface 
(i.e. the interface within a dimer pair) is disrupted during desensitization, and that mutations that 
stabilize this interface prevent desensitization from occurring (Sun et al., 2002). Furthermore, the 
structures suggest that channel opening occurs as a result of direct mechanical coupling of binding 
domain closure to points of contact between the extracellular and transmembrane domains (Gouaux, 
2004). 
 1.1.2.2  Physiological function 
The primary physiological role of AMPARs is to mediate fast synaptic transmission in the central nervous 
system. AMPARs have extremely fast kinetics – they deactivate (that is, shut in the absence of applied 
neurotransmitter) with a time constant of around 1 ms, and they desensitize with a time constant of 
roughly 2 ms (Mitchell and Fleck, 2007; Papke et al., 2011). Whether or not desensitization plays a role 
in shaping receptor responses in vivo has been a somewhat controversial issue. Despite the age of this 
field of research, results continue to be contradictory, even when the results are coming from the same 
lab working on the same synaptic system (desensitization was found to influence responses in the 
mouse endbulb of Held, for P15-P21 mice [Chanda and Xu-Friedman, 2010], but earlier, the opposite 
result was found in the mouse endbulb of Held, for P15-P21 mice [Yang and Xu-Friedman, 2008]). The 
contradictory nature of these findings suggests that a more robust experimental approach would 
provide better insight into the physiological significance of the desensitized state of AMPARs. 
In a different approach to determining the physiological significance of desensitization, a transgenic 
mouse was developed to carry a mutation to the GluA2 subunit that eliminates desensitization (Stern-
Bach et al., 1998; Christie et al., 2010). The mutation was homozygous lethal, but heterozygous mice 
survived until birth, dying shortly thereafter. Interestingly, in these mice, EPSCs in CA1 were found to 
exhibit aberrant facilitation, implying that desensitization might be necessary to limit AMPAR 
responsiveness (Christie et al., 2010). These results unequivocally demonstrate the functional 
importance of the desensitized state in vivo. 
 6 
 
1.1.3  Purinergic ion channel superfamily 
1.1.3.1  Structure 
All purinergic receptors (P2XRs, numbered P2X(1-7)) are ATP-gated, trimeric ionotropic receptors with 
three binding sites. Each subunit has two transmembrane α-helices (TM1 and TM2), a large extracellular 
domain, and intracellular amino- and carboxy-terminal domains. Systematic mutagenesis studies have 
shown that TM1 is unlikely to contribute many residues to the channel lumen (Samways et al., 2008), 
while TM2 most likely is the pore-lining α-helix. A crystal structure of the P2X4R, thought to be in the 
closed conformation, confirmed the aforementioned features (Figure 1.3), and gave evidence that the 
binding site is located between subunits around 45 Å from the membrane (Kawate et al., 2009). The lack 
of crystallographic data for open or desensitized states prevents direct structural comparison as a means 
to determine gating and desensitization mechanisms. 
 
Figure 1.3. The architecture of P2X purinergic receptors. Images were generated from 3I5D, the 
zebrafish P2X4 closed state model (Kawate et al., 2009), using VMD (Humphrey et al., 1996). A, A view 
from the extracellular domain. Xs indicate the proposed location of the ATP binding sites, in the 
extracellular domain at the subunit-subunit interfaces. B, A side view. Grey lines demarcate the 
approximate location of the membrane. 
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Both terminal domains are highly variable across receptors, and they seem to primarily serve as regions 
of post-translational modification and receptor-protein interactions, similar to the M3-M4 loop of 
pLGICs. The N-terminus has been shown to contain a phosphorylation site in P2X2Rs (Surprenant and 
North, 2009). The C-terminus is a long cytoplasmic domain that has considerable variability across 
receptors in the P2X superfamily, and is known to interact with protein-modulators and the 
cytoskeleton (Surprenant and North, 2009). Although on the whole the terminus is quite variable, there 
is a conserved motif near TM2 that is critical for stabilizing the receptor in the membrane (Chaumont et 
al., 2004). 
1.1.3.2  Physiological function 
P2XRs are expressed throughout the central nervous system (North, 2002), and are well-known to be 
crucial to nociception signaling pathways (Burnstock, 1999). Many of the P2XR family members have 
been characterized to at least some degree (Rassendren et al., 1997; Ding and Sachs, 1999a; Khakh et 
al., 1999), but the P2X2R has received more attention than other members because its physiological role 
is better understood. Of particular relevance to our work, it been demonstrated that the P2X2Rs mediate 
fast-synaptic transmission in mouse myenteric neurons (Ren et al., 2003).  
The P2X receptors exhibit slow kinetics relative to most other known NGICs. P2X2Rs were shown to have 
slow rates of activation and deactivation, with an overall kinetic signature more closely resembling that 
of NMDA receptors than that of AChRs or AMPARs (Moffatt and Hume, 2007). In Chapter II, we directly 
compare kinetic properties of many NGICs, highlighting the unusual behavior of P2X2Rs relative to most 
other receptors. 
  
 8 
 
1.2  Post-translational modification of pLGICs 
 
In this section, I will discuss the effects of phosphorylation and cysteine oxidation on the function of 
pLGICs, with a focus on AChRs, particularly the α3β4 AChRs. The discussion about phosphorylation is 
meant to provide background to studies that we hope to complete in the future, and the cysteine 
oxidation discussion is intended as background for Chapter III. 
 
1.2.1  Cysteine modifications of transmembrane and cytosolic proteins 
 
In transmembrane proteins, extracellular cysteine modification is a relatively common phenomenon; for 
example, disulfide bridge formation is often important to ensure proper folding (Sevier and Kaiser, 
2002). Such modifications are typically made in the endoplasmic reticulum and are therefore present in 
extracellular domains. In contrast, cytosolic cysteines are seldom involved in stable disulfide bonds due 
to the highly reducing environment of the cytosol maintained in part through the presence of reductive 
enzymes (Paget and Buttner, 2003). It has been suggested that cells evolved to maintain such a highly 
reducing environment, and that departures from these conditions can adversely affect protein folding 
and function (Åslund and Beckwith, 1999).  
 
Under oxidative stress, an increase in cytosolic reactive oxygen species (ROS) leads to the formation of 
modified cysteine residues; these include sulfinic acid (where the –SH is oxidized to –SOOH), sulfonic 
acid (–SO3H), or, if other cysteines are nearby, disulfide bridges. There are many known cases in which 
these modifications, induced by oxidative stress, can cause a change in protein function. For example, in 
bacteria, the OxyR transcription factor was shown to be activated by oxidative stress, leading to 
transcription of a gene encoding for a reductive protein (Zheng et al., 1998). In human cells, oxidative 
stress has been shown to directly modify SIRT1, a histone deacetylase implicated in suppressing 
inflammation, leading to increased inflammation (Caito et al., 2010). 
 
1.2.2  Cysteine modification and the α3β4 receptors 
 
Cysteine modifications have long been associated with pLGICs; the superfamily even got its original 
“Cys-loop” handle due to a conserved disulfide bond between residues in the extracellular domain 
(Barnard et al., 1987; Cockcroft et al., 1990), the disruption of which impairs both assembly and normal 
conformational changes (Mishina et al., 1985; Green and Wanamaker, 1997). It is thus well established 
that these bridges are essential for normal receptor function. 
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In addition to these well known and vital extracellular modifications, a recent study by Campanucci et al. 
provides evidence that, under oxidative stress, intracellular cysteines of the α3-containing AChRs can be 
oxidized; these modifications have been proposed to cause the reduced synaptic fidelity associated with 
diabetic neuropathy (Campanucci et al., 2010). In this work, the authors examined synapses in the 
superior cervical ganglion (SCG), dissected from mice used in an animal model of hyperglycemia. They 
found that the post-synaptic responses of these neurons to low-frequency stimulation exhibited 
depression when taken from hyperglycemic mice, whereas they saw no depression in the responses of 
SCG neurons from control animals. The group then developed a transgenic mouse with a C239A 
mutation in the α3 subunit (thought to coassemble with the β4 and possibly other subunits to form 
functional channels in the SCG; Mandelzys et al., 1994; Covernton et al., 1994), and found that this 
mutation prevented the loss of fidelity normally seen in hyperglycemic mice. This result lends credence 
to the hypothesis that C239 is oxidized by ROS, leading to a change in the kinetics associated with the 
desensitized state. Assuming the structure is very similar to the highest-resolution cryo-EM structure of 
the closed channel (Unwin, 2005), C239 is located in the M1-M2 linker at the –4’ position, which is close 
to the narrowest point of constriction in the pore. Therefore, it is plausible that a modification of this 
residue could affect ion passage through the receptor. 
 
The very slow recovery from desensitization seen by Campanucci et al. is reminiscent of the loss of 
receptor responsiveness (termed “rundown”) that has been reported in electrophysiological studies of 
neuronal AChRs, including those containing the α3 subunit (Alkondon et al., 1994; Nelson and 
Lindstrom, 1998). Nelson and Lindstrom, using outside-out patches, attempted to prevent this rundown 
by adding a variety of reagents to the intracellular solution, including phosophocreatine, creatinine 
phosphokinase, and Mg-ATP with the catalytic subunit of protein kinase A. While these compounds had 
proven useful in similar studies of other receptors, they were not effective in preventing rundown of α3-
cotaining receptors. The work of Campanucci et al. provides fresh insight into the rundown that has 
hindered electrophysiological study of α3 containing receptors: it is plausible that C239 is oxidized in 
outside-out patch-clamp experiments, since, for example, glucose-rich (i.e. highly oxidizing) media is 
often used in culturing cells for experimentation. 
 
In addition to the rundown phenomenon, a further complication described for the ganglionic receptors 
is the apparent dependence of receptor kinetics on the expression system (Lewis et al., 1997). In this 
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study, very different kinetics were observed for receptors depending on whether they were expressed in 
Xenopus oocytes, mammalian cells, or natively in SCG neurons. The cysteine hypothesis may also 
provide a plausible explanation for these differences, since different cell lines, grown in different media, 
could very well have dissimilar redox potentials. Interestingly, another study has described changes in 
observed rundown dependent on the age of SCG cell cultures; rundown was observed in response to 1 
Hz ACh pulses around day 2 of the culture, but by day 10 receptors exhibited high fidelity responses 
(Campanucci et al., 2008). These time-dependent changes may also partially explain the cell-type 
dependence seen by Lewis et al., since, depending on the expression system, the procedures for 
achieving protein expression have differing intervals between the introduction of DNA/RNA and patch-
clamping experiments. 
 
1.2.3  Is there more to the story of α3 rundown? 
 
Though the works of Campanucci et al. present a compelling story, it remains unknown whether their 
findings of time-dependent and oxidation-state dependent changes in rundown can be extended to 
allow study of these receptors in other expression systems. Such an extension would be useful, since it 
would allow, for the first time, a thorough study of channel kinetics using concentration jumps applied 
to excised patches. 
 
Furthermore, it remains unclear whether the α3-containing receptors mediating transmission in the 
ganglia are purely α3- and β4-containing receptors, or whether these subunits also coexpress with α5 or 
β2. Analysis of mRNA expression levels in the ganglia has shown that α3 and β4 are expressed to a much 
higher degree than the α5 and β2 subunits with which they can co-assemble (De Koninck and Cooper, 
1995). If the findings of Campanucci et al. extend to heterologous expression systems, it would be 
possible to determine whether specific subunit combinations are likely to be mediators of synaptic 
transmission in the ganglia by observing their responses to trains of highly-concentrated ACh pulses. 
 
1.2.4  Known phosphorylation sites of Cys-loop receptors 
 
In addition to the cysteine modifications discussed above, other post-translational modifications can 
alter receptor function, with phosphorylation being one of the best studied. Multiple phosphorylation 
sites have been identified in GABAARs and AChRs (Swope et al., 1999). Sites have also been found in 
members of other superfamilies of receptors (for example, in AMPARs). These sites are thought to be 
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important, with phosphorylation having been proposed to regulate receptor function (Huganir and 
Greengard, 1987) and synthesis (Schroeder et al., 1991). 
 
In particular, many sites have been found in the cytosolic M3-M4 loop of AChRs, in various protein 
subunits. Thus far, the majority of these sites have been located in the δ subunit, using protein isolated 
from the Torpedo electric organ. S361 was shown to be phosphorylated by protein kinase A (PKA), using 
localization through protein sequencing (Yee and Huganir, 1987). Again using direct localization, 
Schroeder et al. demonstrated that S361 and S377 are phosphorylated by PKA and protein kinase C 
(PKC), respectively, and that S362 can be phosphorylated by PKA and/or PKC (Schroeder et al., 1991). 
Further supporting these findings, Safran et al. used synthetic peptides of partial sequences of the M3-
M4 loop to predict that two of the three adjacent serines in positions 360-362 are phosphorylated by 
both PKA and PKC (Safran et al., 1987). Finally, direct sequencing through Edman degradation was also 
used to identify Y372 as a site phosphorylated by protein tyrosine kinase (PTK) (Wagner et al., 1991). 
This study also found that Y355 of the β1 subunit is phosphorylated. 
 
 
 301  M2-M3  M3 Helix     M3-M4 Loop 
human      KRLPATSMAIPLIGKFLLFGMVLVTMVVVICVIVLNIHFRTPSTHVLSEGVKKLFLETLP 
mouse      KRLPATSMAIPLVGKFLLFGMVLVTMVVVICVIVLNIHFRTPSTHVLSEGVKKFFLETLP 
torpedo    QRLPETALAVPLIGKYLMFIMSLVTGVIVNCGIVLNFHFRTPSTHVLSTRVKQIFLEKLP 
           :*** *::*:**:**:*:* * *** *:* * ****:***********  **::***.** 
 
 
 361 
human      ELLHMSRPAE-DGP--SPGALVRRSSSLGYISKAEEYFLLKSRSDLMFEKQSERHGLARR 
mouse      KLLHMSRPAE-EDP--GPRALIRRSSSLGYICKAEEYFSLKSRSDLMFEKQSERHGLARR 
torpedo    RILHMSRADESEQPDWQNDLKLRRSSSVGYISKAQEYFNIKSRSELMFEKQSERHGLVPR 
           .:*****. * : *       :*****:***.**:*** :****:************. * 
 
 
Figure 1.4. An alignment of human, mouse, and Torpedo δ subunits. This alignment illustrates the 
strong conservation of known serine and tyrosine phosphorylation sites. Note that Swope et al. suggest 
that S379 may also be phosphorylated (Swope et al., 1999).  
 
 
Additional phosphorylation sites have been discovered in the fetal γ subunit (Yee and Huganir, 1987; 
Wagner et al., 1991), but these sites are not conserved in mammalian receptors. Interestingly, by 
sequence gazing, it is clear that many of the aforementioned serines and tyrosines of the β1 and δ 
subunits shown to be phosphorylated in the Torpedo AChR are also conserved in mammalian receptors, 
including the human receptors (Figure 1.4). This leaves five potential phosphorylation sites on the 
PTK 
PKC PKA PKC 
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human receptor (δ subunit: S376, S377, Y387, and S392; β subunit: Y357), although the extent to which 
phosphorylation occurs at these sites in human cells is unknown. The low endogenous PKC and PKA 
activity in cultured human embryonic kidney (HEK-293) cells was demonstrated to yield moderate to low 
levels of GABAAR and GluA6 AMPAR phosphorylation at known cytosolic sites (Moss et al., 1992; 
Raymond et al., 1994); however, in both cases, phosphorylation of these sites could be increased by 
transfecting the cells with cDNA encoding for the catalytic subunit of PKA, or by intracellular perfusion of 
PKC. Moss et al. showed that phosphotyrosine levels are dependent on cell type, with low levels of 
phosphotyrosine in HEK-293 cells, but higher levels in cultured SCG neurons (Moss et al., 1995). 
 
In addition to these sites identified in the AChR, many sites have been discovered in the M3-M4 loop of 
mammalian GABAARs. In the murine γ2L subunit, S343 has been shown to be a substrate of PKC (Moss et 
al., 1992), and Y365 and Y367 are known substrates of PTK (Moss et al., 1995). On the β1 subunit, Y384 
and Y386 can also be phosphorylated, but there are no apparent functional effects of these 
modifications (Moss et al., 1995). Finally, on the β1 subunit, S410 can also be phosphorylated by PKC 
(Krishek et al., 1994). 
 
1.2.5  The functional effects of phosphorylation on Cys-loop receptor behavior 
 
Clearly, many phosphorylation sites have been identified, particularly in the intracellular loop of the 
AChR. The effects of modifications to some of these sites have been investigated, both terms of function 
and developmental regulation. On the latter point, Gillespie et al. showed that the δ and β tyrosine sites 
of the AChR can be phosphorylated by muscle specific kinase (MuSK) in transfected quail cell lines 
(Gillespie et al., 1996). MuSK has also been shown to be necessary for neuromuscular junction formation 
in vivo, including for proper synapse-specific expression of AChRs, suggesting a potential developmental 
role of the phosphorylation of AChRs (DeChiara et al., 1996). 
 
Many studies have been conducted to elucidate the effects of phosphorylation on channel kinetics. The 
general trend seen in AChRs is that phosphorylation leads to an increase in the rate of entry into 
desensitization. The initial study of functional effects of phosphorylation showed that the fast 
component of channel desensitization increased in response to cAMP-dependent phosphorylation of 
Torpedo AChRS (Huganir et al., 1986). It was later shown that tyrosine phosphorylation has the same 
effect on these receptors (Hopfield et al., 1988). However, in both of these studies, the methods of 
measuring rates of desensitization were rather imprecise, and as a result, the observed currents, 
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recorded over the course of 10s of seconds, necessarily included channels opening, closing, desensitizing 
and recovering from desensitized states; it is difficult to quantitatively determine what the “fastest-
component” of these studies corresponds to. 
 
A later study, looking at tyrosine phosphorylation of frog embryonic receptors expressed in oocytes, 
attributes the differences between phosphorylated and dephosphorylated receptor behavior to a 
disparity in the kinetics of recovery from desensitization (Paradiso and Brehm, 1998). However, in this 
study, the authors did not consider that entry into desensitization could be important for receptor 
function, since they erroneously claimed that it could not take place in response to brief 
neurotransmitter pulses (for a discussion of the role of desensitization in response to neurotransmitter 
pulses, see Elenes et al., 2006; this topic will also be discussed in detail in Chapter II). 
 
An initial study of the GABAAR demonstrated that there are functional ramifications to cAMP-dependent 
phosphorylation (Moss et al., 1992). Specifically, whole-cell recordings in this study suggest that cAMP-
dependent phosphorylation leads to a reduction in currents. However, it is unclear, due to the 
inherently slow current applications achieved in whole-cell recordings, whether this reduction is due to 
a decrease in receptor responsiveness, a decrease in the gating equilibrium constant, or an increase in 
the rate of entry into desensitization. Another study, this time using phorbol esters to increase PKC 
activity, similarly demonstrated an inhibition of GABA currents, though this study again utilized whole-
cell patch-clamping with relatively slow agonist perfusion times (Sigel and Baur, 1988). 
 
Additionally, it has been shown that vSRC, a tyrosine kinase, led to “enhanced” whole cell currents 
(Moss et al., 1995). Again, though a tyrosine-kinase dependent effect was demonstrated, the exact 
mechanism of current enhancement was obscured by the electrophysiological approach; an increase in 
peak current could be due to decreased entry into desensitization or an increased gating equilibrium 
constant. From the studies conducted so far, a general trend is that serine phosphorylation, via PKC or 
PKA, leads to some kind of inhibition of currents, while tyrosine phosphorylation leads to an 
enhancement. 
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1.2.6  Physiological relevance – the missing piece to the puzzle 
 
The majority of research into the effects of phosphorylation on desensitization was conducted in the 
late 1980s and early 1990s. At this time, the physiological role of desensitization remained elusive. 
Research demonstrating that desensitization limits the physiological responses of AMPARs to high 
frequency trains did not appear until the mid 1990s (Trussell and Fishbach, 1989; Raman and Trussell, 
1995). Despite this work, recent studies have yet to make the connection between the effects of 
phosphorylation on entry into desensitization and plasticity (for example, see Paradiso and Brehm, 
1998). 
 
Changes in the phosphorylation state of neurons could plausibly serve as a regulatory mechanism for 
governing synaptic transmission, and could potentially lead to synaptic plasticity (this has been 
demonstrated, for example, with AMPA receptors in hippocampal slices; Pettit et al., 1994). It has yet to 
be determined, however, whether the measured changes in kinetics of entry into desensitization and 
recovery from desensitization can impact the responses of Cys-loop receptors to trains of pulses 
delivered at physiologically relevant frequencies. 
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1.3  AChR interactions with other proteins and the membrane 
 
Here we will focus on interactions involving the AChR, other proteins, and the membrane, to lay the 
groundwork for experimental work in Chapter III, where we investigate potential interactions involving 
the α3β4 AChRs. We also discuss the possibility that changes in these interactions might underlie the 
well-documented loss of function of α3β4 AChRs in excised patches. 
 
1.3.1  Interactions between AChRs and modulatory proteins 
 
Modulatory proteins are known to have effects on AChR function, mediated through association with 
both intracellular and extracellular domains of the receptors. Recently, the number of proteins known to 
interact with AChRs has greatly increased, and these protein interactions have been shown to affect 
receptor assembly, trafficking, and function (Jones et al., 2010). 
 
The earliest identified protein known to interact with AChRs is rapsyn, which was discovered to cluster 
with AChRs in the Torpedo electric organ and in rat myotubes (Porter and Froehner, 1985; Bloch and 
Froehner, 1987; Millar and Harkness, 2008). It has since been determined that rapsyn is involved in a 
signaling cascade that leads to AChRs being postsynaptically targeted to presynaptic boutons, as follows: 
agrin, a presynaptically-released protein, acts extracellularly on the post-synaptic muscle, ultimately 
leading to activation of transmembrane muscle specific kinase (MuSK) (Glass et al., 1996; DeChiara et 
al., 1996). MuSK activation leads to tyrosine phosphorylation of the AChR β1 subunit’s intracellular M3-
M4 loop (Gillespie et al., 1996), a modulation necessary for rapsyn to cluster the receptors (Borges et al., 
2008). It has been demonstrated that MuSK is necessary for proper clustering of AChRs in vivo, 
highlighting the importance of this series of protein interactions for AChR trafficking (DeChiara et al., 
1996). 
 
Rapsyn is just one of many proteins known to interact with the AChR. Others, especially intracellular 
protein kinases, can directly modulate receptor function (Swope et al., 1999; Jones et al., 2010). The 
large intracellular M3-M4 loops of most AChR subunits contain known phosphorylation sites. There are 
many well known cases of phosphorylation sites in this loop affecting receptor function in the Torpedo 
AChR (Huganir and Greengard, 1987), as discussed in Section 1.2. Pertinently for our discussion here, 
both cAMP induced serine phosphorylation (Huganir et al., 1986; Miles et al., 1987; Smith et al., 1987) 
and tyrosine phosphorylation (Hopfield et al., 1988) have been shown to increase the rate of “fast 
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desensitization” of AChRs, although the coarse electrophysiological measurements in these studies 
leave room for quantifying the specific kinetic changes taking place. 
 
The muscle receptor is not the only AChR with known intracellular interactions with protein kinases; 
such interactions have also been described for neuronal receptors, including the α7 homomeric and β4-
containing AChRs. Both of these receptors have been shown to interact with Src, Fyn, and Lyn, all three 
of which are Src-family kinases (SFKs) that phosphorylate tyrosine residues (Jones et al., 2010). In the 
case of the α7 homomers, treatment with genistein, a tyrosine phosphorylation inhibitor, increased α7 
mediated currents in oocytes, while phosphatase inhibition with pervanadate led to a decrease in 
currents (Charpentier et al., 2005). This study also demonstrated that making Y386A and Y442A 
mutations (i.e. eliminating M3-M4 tyrosine phosphorylation) led to increased receptor responsiveness, 
consistent with the notion that tyrosine phosphorylation inhibits currents. Of note, another study found 
that tyrosine phosphorylation of neuronal nicotinic receptors via the SFKs led to an enhancement of 
α3β4α5 mediated activity (Wang et al., 2004). In both of these works, the electrophysiological 
experiments again leave room for multiple underlying kinetic explanations. 
 
In addition to the discussed intracellularly associated proteins, others are thought to interact with the 
extracellular domains of AChRs. lynx1 and lynx2 are anchored to the membrane, and are expressed in 
various neuronal cell types. lynx2, when co-expressed with α7 or α4β2 receptors in HEK-293 cells, co-
immunoprecipitates with the receptors (Tekinay et al., 2009). In oocytes, co-expression of lynx1 and 
lynx2 with the same receptors leads to an increase in the EC50 and rate of desensitization (Tekinay et al., 
2009). Again, the specific channel kinetics affected by lynx1 and lynx2, leading to the observed 
increases, cannot be determined from the electrophysiological measurements of the study. However, 
lynx1 and lynx2 exemplify that proteins can directly interact with and modulate AChR function, through 
interactions with the extracellular domain. 
 
Finally, extracellular interactions between α7- and α4-containing AChRs and β-amyloid (Aβ) protein 
(widely considered an important player in Alzheimer’s disease) have been well-studied, although results 
remain controversial (Buckinham et al., 2009). Neurons that accumulate Aβ have also been shown to 
express increased numbers of α7 and α4-containing AChRs (Wevers et al., 1999). A recent study has 
shown that deletion of the α7 gene, in addition to having no apparent detrimental cognitive effects, also 
prevented cognitive deficits seen in a mouse model of Alzheimer’s disease (Dziewczapolski et al., 2009). 
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Interestingly, accumulation of Aβ plaques was not prevented, implying that the extracellular protein 
interaction between the plaques and the α7 AChRs is a prerequisite for development of cognitive 
impairment associated with Alzheimer’s. These results suggest the possibility of treating Alzheimer’s 
disease with drugs that impair Aβ association with α7. 
 
Findings regarding the functional effects of Aβ interactions on AChR kinetics have been somewhat 
contradictory (Buckinham et al., 2009). Aβ inhibition of post-synaptic responses of cholinergic neurons 
in the hippocampus has been reported (Pettit et al., 2001). Currents resulting from α4β2 and α7 
receptors heterologously expressed in Xenopus oocytes have been experimentally inhibited by 
applications of Aβ1-42 (the isoform of Aβ associated with Alzheimer’s disease) (Tozaki et al., 2002). 
Another group found that Aβ1-42 blocks channel opening of α7 receptors in a non-competitive manner 
(Grassi et al., 2003). At odds with these two studies, it has been found that Aβ1-42 enhanced α7 mediated 
currents in Xenopus oocytes (Dineley et al., 2002). Given the coarse nature of two-electrode voltage 
clamping technique employed by all three groups, as well as the contradictory results, more 
investigation is necessary to determine the specific kinetic mechanism through which Aβ1-42 interactions 
affect channel function. Overall, while the particular effects of the interaction remain controversial, it 
appears likely that Aβ1-42 can modulate channel function through direct interaction with the AChR 
extracellular domain.  
 
1.3.2  Effects of lipids on AChR function 
 
It is has long been established that the M4 helix is exposed to lipids, based on studies of the accessibility 
of residues in this helix (Blanton and Cohen, 1992; Blanton and Cohen, 1994). Furthermore, X-ray 
crystallographic structures of bacterial members of the pLGIC superfamily provide evidence of strong 
protein-lipid interactions in M4, since lipids were bound to the protein in the solved structure; such 
binding implies that these interactions have high enough affinity to survive the harsh washing involved 
in protein purification (Baenziger and Corringer, 2010).  
 
It is also known that, in order to purify the Torpedo AChR, the receptor needs to remain in the presence 
of lipids, and be reconstituted in a membrane with the right proportion of anionic and neutral lipids; if 
these conditions are not met, the receptor will ultimately not be functional (Fong and McNamee, 1986). 
These non-functional receptors exist in an unresponsive state that is distinguishable from the traditional 
desensitized state of AChRs; recently, it was proposed that this “uncoupled state” is also distinct from 
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the closed state (daCosta and Baenziger, 2009). Using solvent accessibility assays, daCosta and Baenziger 
demonstrate that, in uncoupled receptors, the M4 helix is physically separated from the region of the 
extracellular domain near the Cys-loop, with which it has close proximity in the “basal” (i.e. normally 
activatable) state. They furthermore suggest that the loss of normal M4–extracellular domain 
interactions causes uncoupling of binding from channel gating, thereby leading to a loss of function. This 
hypothesis was tested with experiments involving Torpedo receptors, reconstituted in membranes 
containing a physiologically typical lipid mixture (leading to functional receptors) and in membranes 
lacking phosphatidic acid and cholesterol (leading to non-functional receptors). Using allosteric 
modulators to change the state of either the pore or the binding domain, daCosta and Baenziger found 
that, while effects of allosteric modulators were appropriately transferred between these domains in 
the functional receptors, the same effects were not transmitted between the domains in the 
“uncoupled” receptors. Furthermore, daCosta and Baenziger found the binding affinity of the uncoupled 
state to be similar to that of the activatable channel, but substantially lower than the affinity of the 
desensitized state (which has the highest binding affinity of known conformations; Boyd and Cohen, 
1980). 
 
The evidence of changes in membrane composition leading to changes in the coupling of the binding 
and channel domains implies (1) that there are likely to be specific sites of lipid-protein interaction in 
M4, and (2) that this lipid-exposed α-helix is intimately linked to channel gating, despite its distance 
from the channel lumen. In further support of these notions, mutagenesis of lipid facing residues has 
been shown to affect gating properties of the channels. For example, mutation of the Torpedo αC418 
residue to tryptophan led to prolonged channel openings at low concentration, suggesting a decreased 
closing rate constant (Li et al., 1992); in the mouse muscle AChR, mutations of the αC418 and αT422 
residues to alanines led in each case to decreases in the channel open time at low concentration, 
implying an increased closing rate constant (Bouzat et al., 1998). 
 
The mechanism by which M4 helix interactions interfere with normal conduction of binding signals to 
the pore remains a mystery. Antollini et al. suggest that varying the amount of cholesterol in the 
membrane can alter the tilt of the M4 helix; taken together with the work of daCosta and Baenziger, this 
change in tilt could influence the proximity between the binding domain and the C-terminus of M4 
(Antollini et al., 2005; Baenziger and Corringer, 2010); cholesterol might be necessary to stabilize the 
proper degree of tilt of M4.  
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Cholesterol is also thought to stabilize the transmembrane domain of AChRs by filling in cavities (termed 
“non-annular cholesterol binding sites”) between α-helices (Brannigan et al., 2008). In a molecular 
dynamics study, Brannigan and coauthors showed that inclusion of cholesterol in the non-annular sites 
prevented the collapse of the Torpedo 2BG9 structure that normally occurs in such simulations. Thus, it 
is possible that lipid-protein interactions are also needed for proper protein stability. 
 
1.3.3  Could changes in channel interactions with lipid or protein underlie AChR rundown in outside-
out patches? 
 
The existence of time-dependent changes in receptor kinetics (as observed through patch-clamp 
recording) has been well-described. Specifically, time-dependent increases in the rate of entry into 
desensitization have been demonstrated in neuronal GABA receptors (Frosch et al., 1992), neuronal 
nicotinic receptors (native – Lester and Dani, 1994; heterologously expressed – Nelson and Lindstrom, 
1999), and in heterologously expressed serotonin receptors (Mott et al., 2001). The problem has been 
especially troublesome for study of α3-containing AChRs, since these receptors rapidly enter non-
conductive states in outside-out patches of membrane, rendering impossible a thorough 
characterization (Nelson and Lindstrom, 1999).  
 
Since channel activity does not suffer from the same rundown in cell-attached patching, the rundown 
must result somehow from patch excision. Clearly, in excised patches of membrane, interactions 
between AChRs and intracellular proteins will be lost. Of the protein-AChR interactions discussed above, 
a potential culprit for this lost interaction could be tyrosine phosphorylation via SFKs, which have been 
shown to substantially increase α3β4α5 peak currents (Wang et al., 2004). However, it has been 
reported that the basal level of tyrosine kinase activity in HEK-293 cells is low (Moss et al., 1995), so it is 
unclear whether loss of this protein could be the culprit. 
 
A second possibility is that patch excision puts unnatural strain on the membrane, which could in turn 
force channels into desensitized state (or, possibly, uncoupled states). It has been shown that patch 
formation in the cell-attached configuration leads to stress on the membrane within the patch (Suchyna 
et al., 2009). It is conceivable that patch-excision, which requires pulling on the membrane much harder 
than in cell-attached patching, could affect gating, similar to how changing the lipid environment can 
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affect kinetic properties. Further investigation is necessary to determine the mechanism responsible for 
the time-dependent rundown observed in α3-containing AChRs. 
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1.4  Deriving kinetic observables from models 
 
Figure 1.5. General model for a receptor with two binding sites. “A” represents agonist, “C” represents 
the closed state, “O” open, “D” desensitized. KD is defined as k–/k+, and JD as j–/j+, θ0 as β0/α0, θ1 as β1/α1, 
and θ2 as β2/α2. kD+ is the rate of entry into desensitization. 
 
One of the great benefits of patch-clamp electrophysiology is the wealth of detailed kinetic information 
gained through recordings. This information can be fit to models that can be tested for predictive 
strength, giving an indication of the extent of our 
understanding of a receptor’s behavior. In this section, 
derivations of some useful quantities (including the 
EC50) will be carried out, using the model in Figure 1.5.  
In Section 1.5 of the introduction, the computational 
approach that we used for testing models will be 
described in detail. 
 
1.4.1  Deactivation timecourse 
Deactivation is the process of channel shutting in the 
absence of externally applied neurotransmitter. 
Physiologically, this process occurs during fast-
synaptic transmission upon removal of 
neurotransmitter from the cleft. As we will 
Figure 1.6. Comparison of burst duration and 
deactivation timecourse. Black and green traces 
have different current scales. The macroscopic 
deactivation timecourse (shown in green) is the 
sum of many microscopic bursts of single channel 
activity (shown in black). The time constant of 
deactivation is the same as the average burst 
duration. 
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demonstrate, deactivation includes both channel closure (that is, transition to a closed state) and 
desensitization. Note that the terms “deactivation timecourse” and “burst duration” will be used 
somewhat interchangeably, because the deactivation timecourse, determined from macroscopic 
recordings, is the sum of many individual “bursts” (series of single-channel openings recorded in the 
presence of a very low concentration of agonist). Because the deactivation timecourse is the sum of 
many individual bursts, the deactivation time constant and the burst duration need to have the same 
average length (Elenes et al., 2006); see Figure 1.6. 
It is of interest to determine the average amount of time that it takes for a channel to deactivate, since 
the reciprocal of this quantity is the rate of deactivation. We start with the relation: 
 
 
 
This relation holds true if only diliganded states contribute appreciably to the deactivation timecourse 
(as is the case for, for example, the AChR). For some receptors, it may be necessary to add terms for the 
monoliganded states as well. Since the average time spent in any state is equal to {∑ (exit rates)}-1,  
 
             
 
By definition, bursts must begin with an opening. Classical derivations of the number of openings within 
a burst did not include OA2 → OA and OA2 → DA2 transitions out of the open state (Colquhoun and 
Hawkes, 1981). The number of openings in one of these “Colquhounian bursts” is given by: 
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The Colquhounian burst expression overestimates the number of openings, since it is based on a model 
without OA2 → OA and OA2 → DA2 transitions. An OA2 → OA transition can be considered to terminate 
the burst since OA → CA will follow immediately after OA2 → OA, and since, once a channel is in CA, it 
can no longer reach OA2 in the absence of agonist. To determine the number of openings in a “true 
burst” (a burst including OA2 → OA and OA2 → DA2 transitions), first consider the number of times a 
Colquhounian burst would have been terminated by an OA2 → OA or OA2 → DA2 transition, had the 
transitions been allowed in the classical derivation: 
 
        
  
We can now get the number of openings per true burst using an alternate expression for the number of 
terminations per Colquhounian burst: 
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Since a burst by definition ends with the last visit to the open state, all sojourns in the closed state must 
be preceded and followed by open state sojourns. Therefore, 
 
 
 
The derived expressions can be substituted into the expression for the average burst duration to get 
“τdeactivation” (the average time constant of deactivation):  
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The average rate of deactivation is given by the inverse of the time constant, i.e., (τdeactivation)
-1. Note that 
the above expression gives the average time it takes for a channel to deactivate, assuming that only 
diliganded states contribute significantly to the deactivation timecourse. However, the complexity of 
this expression prevents us from gaining qualitative insight into deactivation.  
To get a much simpler expression that is still fairly accurate for most receptors, we will assume that the 
duration of closed state sojourns is much shorter than that of the open state sojourns (the result of this 
derivation was first presented in Grosman and Auerbach, 2001). This assumption is valid for many 
receptors, including, for example, the muscle AChR, which is open roughly 95% of the time during a 
burst. The general expression now reduces to:  
 
               
 26 
 
 
The expression for the deactivation time constant now reduces to: 
                    
This expression has an advantage over the general one since we can easily define the probability of 
desensitizing during deactivation: 
 
         
 
This derivation implies that, for a generic receptor, there is a non-zero probability of desensitizing during 
deactivation. The extent to which this desensitization affects receptor responses to physiological stimuli 
depends heavily on the values of the rate constants, which vary substantially across receptors. The 
question of whether desensitization affects receptor responsiveness is investigated experimentally in 
great detail in Chapter II. 
1.4.2  Desensitization timecourse 
Just as the deactivation timecourse has a single-channel parallel in the burst duration, so too the 
macroscopic desensitization timecourse has single-channel equivalent: the “cluster duration”. A cluster 
is a series of openings separated by brief closures, in the presence of highly saturating agonist (as 
opposed to a burst, which occurs when the concentration of agonist is very low). A cluster can be 
thought of as a series of bursts, the last one of which is terminated by desensitization (Sakmann et al., 
1980). In macroscopic recordings, the timecourse of entry into desensitization is measured by stepping 
the concentration of agonist from zero to saturating levels, after which the only route of exit from OA2 is 
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OA2 → DA2 (ligand unbinding would be immediately followed by rebinding under highly saturating 
conditions, essentially preventing OA2 → OA and CA2 → CA events from occurring during a cluster).  
Clusters by definition begin and end with sojourns in the open state, flanked by long-lived shuttings that 
are sojourns in the desensitized state. To simplify the derivation of the cluster duration, we will assume 
that the system is in equilibrium. This assumption is valid for deriving the mean cluster duration, since 
single-channel recordings of clusters are made long after initial agonist exposure. However, the 
assumption may not necessarily hold true for macroscopic timecourses, which are recorded just after a 
concentration jump (i.e. not at equilibrium). For the simple model presented in Figure 1.5, it would not 
matter whether the recording was made at equilibrium (single-channel) or after a concentration jump 
(macroscopic), since in either case the series of openings will have the same starting point (OA2), and 
since, for a Markov model, the history of states leading up to OA2 does not make a difference in 
subsequent state transitions. However, in theory, it is possible to imagine a model with multiple long-
lived open states, such that the open state most likely to be visited first would depend on whether the 
experiments were conducted at equilibrium. For such a model, the cluster duration and the 
desensitization timecourse would not necessarily have the same average length. 
With this caveat in mind, assuming equilibrium conditions, we can reduce the model presented in Figure 
1.5 to that shown in Figure 1.7, based on the thermodynamic principle of microscopic reversibility, 
which states that, in a thermodynamic cycle connecting n states, there are only (n-1) degrees of 
freedom for the equilibrium constants; one of the n equilibria is “set” by the other (n-1) (discussed in 
detail in Colquhoun et al., 2004). At equilibrium, only (n-1) equilibrium constants need to be considered 
to fully describe a system. 
 
 28 
 
 
Figure 1.7. Equilibrium analysis model. This model is the same as the one presented in Figure 1.4.1, 
modified based on equilibrium analysis. For each thermodynamic cycle, one set of transitions can be 
removed without affecting the state distribution at equilibrium. 
 
The average cluster duration can be derived relatively easily from the linearized model presented in 
Figure 1.7. One way of deriving the cluster duration is to sum the total duration spent during a cluster in 
each of the states, multiplied by the average number of visits to each state. For an n-state model, this 
method can be expressed mathematically as: 
 
 
 
With the time in each state equaling {∑ (exit rates)}-1, this expression is (in part): 
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Simplifying the expression for the average cluster duration, and rewriting it in terms of equilibrium 
constants, leads to the following expression: 
 
         
 
where τdesensitization is equal to the average cluster duration. If the concentration is sufficiently high, 
τdesensitization depends only on the open probability and the rate of entry into desensitization: 
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This result is expected, since at high concentrations and near-unity open probability, the timecourse of 
entry into desensitization should be equal to the inverse of the rate of entry into desensitization. 
1.4.3  The EC50 depends on many parameters 
The EC50 is a quantity used extensively in pharmacology. It is defined as the concentration of agonist 
that, when applied in a step-wise fashion to a large pool of receptors, elicits a half maximal peak 
response. The relationship between this parameter and underlying kinetic phenomena is complex, 
depending on both gating and binding (Grosman and Auerbach, 2000). To give insight into this 
complexity, we will derive an expression for the EC50 of the model presented in Figure 1.5, with the 
removal of the desensitized state. Inclusion of the desensitized state leads to the peak occurring at a 
non-equilibrium state distribution, greatly complicating the derivation. We will approach the EC50 
numerically in Section 1.5 to allow inclusion of the desensitized state, and we will compare the extent to 
which the inclusion of the desensitized state affects the result. 
The main simplification introduced by removing the desensitized state from the model is that the 
“peak”, which is approached asymptotically, occurs at equilibrium (see Figure 1.10 in Section 1.5). This 
enables equilibrium analysis of the model under consideration, as was done in Section 1.4.3. We will use 
here the same simplified, linearized model (without the desensitized state) to derive the EC50. 
The EC50 is the concentration at which the peak current is half maximal. For the case under 
consideration here, an equivalent and more useful definition of the EC50 is the concentration at which 
the open probability is one-half the maximal open probability. The first step in obtaining the EC50 is to 
determine the fractional occupancies of each of the six states at equilibrium. We constrict the fractional 
occupancies so that they add up to unity; this definition will allow us to equate fractional state 
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occupancies with occupancy probabilities. So, with PO = (fractional occupancy of O) = (probability of 
being in O),  
 
 
 
The model in Figure 1.7 directly yields five more equations, from the equilibria. Taken with the above 
equation, there now is a system of 6 equations with six unknowns.  
                     
 
Using these six equations, we can solve for POA2 as a function of the agonist concentration, as follows: 
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The relevant quantity of interest for calculating the EC50 is the sum of the open state occupancies, i.e., 
(PO + POA + POA2). This can now easily be determined: 
 
 
Equating this expression with the open probability at the EC50 (which is equal to 0.5*[θ2/(1 + θ2)] ) gives 
a quadratic expression for the agonist concentration. Solving this quadratic yields a positive and 
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negative root, the former of which is the EC50. Clearly, the EC50 is a very complex parameter, even in this 
simplified case.  
It is worth emphasizing that it is difficult to gain insight into receptor kinetics by experimentally 
determining the EC50. In particular, the EC50 is not a direct reflection of agonist binding, but is instead a 
compound function of binding and gating. Further complications arise from the nature of experiments 
typically used to determine the EC50 (whole-cell or two-electrode voltage clamping experiments); in 
these experiments, artifacts introduced by poor agonist perfusion can affect the peak amplitude, in a 
manner inconsistent from patch to patch. Thus, while the EC50 can give some qualitative insights into the 
effect of, for example, a mutation, it is not an ideal parameter for quantifying the kinetic behavior of a 
receptor.  
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1.5 Computational Modeling 
1.5.1 Modeling Theory  
The connectivity of functional states of ion channels is modeled using Markov schemes; a typical Markov 
scheme was presented in Figure 1.5. These models are usually developed in an attempt to encapsulate 
the kinetic parameters observed experimentally. One of the often-missed benefits of generating a 
model is the ability to theoretically test it against complex pulse protocols, to see if it can correctly 
predict experimental observations. We developed a program to enable us to test these results, using 
well-known Q-matrix methods (Colquhoun and Hawkes, 1995). We will now outline the logical flow of 
this program. 
To calculate the responses of a given model, it is first necessary to number the states (for our purposes, 
the particular choice of numbering scheme is arbitrary). Based on this numbering scheme, a “Q-Matrix” 
can be developed. A Q-Matrix is a matrix containing transition rates between different states, where a 
transition from state i to state j is assigned to matrix element Qij, and where Qii is equal to the sum of all 
transitions in row i, multiplied by negative one. The Q matrix for the model presented in Figure 1.5 is 
presented in Figure 1.8. 
 
 
Figure 1.8. Q matrix for the model presented in Figure 1.5. Entries Qii are the negation of the sum of 
rates out of state i. 
 
With our program, we are ultimately interested in varying the agonist concentration (“A” in the Q matrix 
in Figure 1.8) as a function of time. However, for the time being, we will consider how a system relaxes 
to equilibrium given an initial state distribution with a constant agonist concentration. Define p(t) to be 
a vector of the occupancy probabilities. The Q-matrix is constructed in a way such that  
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dp(t)/dt = p(t)Q 
This equation has the general solution:  
p(t)=p(0)*eQt 
Note that the matrix exponential is a well defined function for all nxn matrices; if Q is an nxn matrix, 
then eQt is also an nxn matrix.  
An important property of an nxn Q-matrix is that it has (n-1) positive eigenvalues (the nth eigenvalue is 
zero), denoted “λi”, and that each of these is the reciprocal of the time constant for a given state. Note 
that exactly one of the time constants has to depend on the rest, which is the reason why there are (n-1) 
non-trivial eigenvalues. 
The general solution presented above can be rewritten as  
p(t)=p(0)*∑Aie
-λ
i
t 
where Ai are the “spectral matrices” of Q. Every nxn matrix X with eigenvalues λi can be decomposed 
into n nxn spectral matrices, such that f(X) = ∑Ai*f(λi). For a diagonal matrix, Ai are matrices with zeros 
everywhere except for at element Aii, which is equal to one. To generate these matrices, first consider Q 
to be a set of column vectors, i.e. Q = [Q1 Q2 Q3 … Qn]. Each Qi will be a kx1 matrix. Next find Y = Q
-1, and 
denote the ith row of Y to be vector yi. Each yi will be a 1xk matrix. Spectral matrices Ai are generated as 
follows: 
Ai = Qiyi 
We can now easily calculate p(t), which is the state occupancy of our model at any time t, given an initial 
distribution p(0). To determine p(t) as the model relaxes from p(0) to its equilibrium state distribution, 
the logical flow of the program is as follows: 
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where tstep is the length of a time step, tinit and tfinal are the start end time for the calculation. 
Now that we can generate a plot for a given set of external conditions, we can easily extend the model 
to account for variable external conditions. If the agonist concentration changes, then so too does Q 
(because Q is a function of agonist concentration). As a result, the initial parameters will need to all be 
recalculated each time the conditions are changed throughout the protocol. Also, once a new set of 
conditions is reached, we will need to consider p(tfinal) of the previous step to be p(tinit) of the current 
step. With these changes in mind, we can now calculate the responses of a model to any arbitrary series 
of pulses, granting us the ability to test any model for its ability to predict responses to nuanced pulse 
protocols. 
 
Figure 1.9. A model of the adult-muscle, α1β1δε AChR. The values of the rate constants of ACh are 
taken from values published in our own work and in the work of others (see Chapter II for more 
discussion of this model and its rates). The dotted transition is only available to channels when the 
concentration of externally applied neurotransmitter is zero. 
Setting up initial parameters 
(1) Calculate eigenvalues λi for Q 
(2) Separate Q into Qi 
(3) Find Y and separate it into Yi 
(4) Determine Ai 
 
Plot generation – relaxing system to equilibrium 
Use p(0), Ai and λi to calculate  
p(t), for t = (tinit + tstep, tinit + 2*tstep, … , tfinal) 
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1.5.2 Testing the program with AChR benchmarks – deactivation and desensitization timecourses, 
and the EC50 
In this section we will test the ability of the model in Figure 1.9 to reproduce the timecourses of entry 
into desensitization and deactivation, and we will also examine the predictions for the EC50, with and 
without inclusion of the desensitized state. 
By applying a short (1-ms) “pulse” of agonist, and then allowing the system to relax in the absence of 
agonist, the time constant of deactivation can be determined. The model in Figure 1.9 generates a 
timecourse of deactivation that, when fit, gives a time constant of deactivation of 0.99 ms. This time 
constant is in relatively good agreement with experimental values, which are near 1 ms (Elenes et al., 
2006). Similarly, by applying a long pulse of highly concentrated agonist, a timecourse of desensitization 
is generated; when fit, this gives a time constant of entry into desensitization of 77.6 ms, which is a bit 
on the slow side (Franke et al., 1993), but also in agreement with some of our own measurements (see 
Chapter IV). 
 
 
Figure 1.10 The EC50 in models with and without desensitization. A, Traces for the model in Figure 1.9 
with the inclusion of the desensitized state. The blue trace shows the response to a highly concentrated 
pulse of agonist (10-M ACh) in order to establish the maximal peak value (0.96); this maximal value is 
the same as the open probability of a channel within a cluster. The red trace shows the half maximal 
response of the model, which corresponds to an EC50 value of 24 µM. B, Traces for the model without 
the desensitized state. The blue trace corresponds to 10-M ACh, and the red trace shows the half 
maximal response, corresponding (again) to an EC50 value of 24 µM. 
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Results from numerically determining the EC50 values of the receptor are presented in Figure 1.10. The 
approximation made in Section 1.4.3 in deriving the EC50 was apparently a good one, since inclusion of 
the desensitized state only very slightly affected the EC50 value. This finding is not a surprise, since, for 
the model under consideration, very little desensitization is expected to occur within the rising phase of 
the current timecourse (this notion is a result of the particular characteristics of the model under 
consideration, in which the rate of entry into desensitization is relatively slow compared to the opening 
rate and the binding rate for agonist concentrations in the µM range). 
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Chapter II – Desensitization of neurotransmitter-gated ion channels during high-frequency 
stimulation: a comparative study of Cys-loop, AMPA, and purinergic receptors1 
Changes in synaptic strength allow synapses to regulate the flow of information in the neural circuits in 
which they operate. In particular, changes lasting from milliseconds to minutes (“short-term changes”) 
underlie a variety of computational operations and, ultimately, behaviors. Most studies thus far have 
attributed the short-term type of plasticity to activity-dependent changes in the dynamics of 
neurotransmitter release (a presynaptic mechanism) while largely dismissing the role of the loss of 
responsiveness of postsynaptic receptor channels to neurotransmitter owing to entry into 
desensitization. To better define the response of the different neurotransmitter-gated ion channels 
(NGICs) to repetitive stimulation without interference from presynaptic variables, we studied eight 
representative members of all three known superfamilies of NGICs in fast-perfused outside-out patches 
of membrane. We found that the responsiveness of all tested channels declines along trains of brief 
neurotransmitter pulses delivered at physiologically relevant frequencies to an extent that suggests that 
the role of desensitization in the synaptic control of action-potential transmission may be more general 
than previously thought. Furthermore, our results indicate that a sizable fraction (and, for some NGICs, 
most) of this desensitization occurs during the neurotransmitter-free interpulse intervals. Clearly, an 
incomplete clearance of neurotransmitter from the synaptic cleft between vesicle-fusion events need 
not be invoked to account for NGIC desensitization upon repetitive stimulation. 
2.1 Introduction 
During fast synaptic transmission, series of brief pulses (<1 ms in duration (Magleby and Stevens, 1972; 
Clements, 1996; Dudel et al. 1999)) of highly concentrated neurotransmitter impinge on the 
postsynaptic membrane at frequencies at least as high as ~200 Hz (Hennig and Lømo, 1985; Saviane and 
Silver, 2006). The peak postsynaptic response to each pulse may increase or decrease along such trains 
to an extent that can affect the flow of action potentials. In turn, this phenomenon allows synapses to 
perform a variety of computational tasks underlying such diverse behaviors as sound localization, 
sensory adaptation, the processing of moving sensory images and intestinal peristalsis (Fortune and 
Rose, 2001; Stevens, 2003; Abbott and Regehr, 2004; Grande and Spain, 2005). This “short-term” 
plasticity results from transient changes (lasting from milliseconds to minutes) in some of the properties 
of the presynaptic terminal, the postsynaptic terminal, or both (Zucker and Regehr, 2002). 
                                                          
1
 This Chapter is adapted from Papke et al. 2011 (Journal of Physiology, 2011, 589, 1571-1585) 
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Most studies thus far have attributed the origin of short-term synaptic plasticity to presynaptic changes, 
including changes in the probability of synaptic-vesicle fusion and the size of the pool of release-ready 
vesicles (Zucker and Regehr, 2002). Moreover, even changes in the number of neurotransmitter 
molecules per vesicle and variations in the kinetics and extent of fusion-pore opening have been 
suggested to play a role (Chen et al. 2004). The involvement of postsynaptic changes, on the other hand 
(specifically, the progressive loss of ionotropic-receptor responsiveness to neurotransmitter owing to 
desensitization), has received much less attention and has been dismissed for most synapses. A few 
glutamatergic synapses involved in the processing of visual (Chen et al. 2002) and auditory information 
(Otis et al. 1996; Brenowitz and Trussell, 2001; Wong et al. 2003; Koike-Tani et al. 2008; Chanda and Xu-
Friedman, 2010), however, are notable exceptions. At least to some extent, we believe that the little 
consideration given so far to postsynaptic mechanisms stems from the common misconception that 
desensitization can only take place while neurotransmitter is present in the extracellular solution. This 
idea is often followed by the inference that, since neurotransmitter is present in the synaptic cleft for 
only very brief intervals at a time and entry into desensitization is comparatively slow, the extent of 
desensitization during synaptic transmission must be negligible. 
Appreciable desensitization during long stretches of repetitive stimulation has been demonstrated to 
occur in wild-type AMPARs (Raman and Trussell, 1995) and in lab-engineered, as well as naturally-
occurring, gain-of-function mutants of the muscle AChR (Elenes et al. 2006, 2009), but it is unknown 
whether this phenomenon is a general property of all wild-type neurotransmitter-gated ion channels 
(NGICs). Such a finding would suggest a novel functional role for the well-conserved desensitized 
state(s), an often-overlooked aspect of postsynaptic-channel function, during information processing in 
the nervous system (Jones and Westbrook, 1996). 
Unfortunately, disentangling the relative contributions of presynaptic and postsynaptic events to short-
term plasticity using intact synapse preparations is not trivial because measurement of the postsynaptic 
response to presynaptic stimulation necessarily depends on both facets of transmission. In addition, 
appropriate methods to selectively block the presynaptic or postsynaptic contributions are not readily 
available for all the NGICs and, for example, some of the pharmacological agents that prevent 
desensitization of AMPARs are not specific and, instead, also affect presynaptic-vesicle release and other 
aspect of the kinetics of these channels (Diamond and Jahr, 1995; Isaacson and Walmsley, 1996; 
Ishikawa and Takahashi, 2001). It is perhaps these difficulties that underlie the somewhat conflicting 
reports produced thus far. 
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We decided to isolate the postsynaptic contribution to short-term depression in a manner that 
minimizes the ambiguities associated with the study of intact synapses. To this end, we studied the 
responses of representative members of all three known superfamilies of NGICs to the repetitive 
application of brief pulses of neurotransmitter in fast-perfused outside-out patches of membrane. Our 
results indicate that the peak-current responses of all tested NGICs decrease markedly along trains of 
high-frequency stimulation, suggesting that desensitization of postsynaptic receptor channels might well 
be a general mechanism contributing to short-term synaptic depression. 
2.2 Methods 
 
2.2.1 cDNA clones, mutagenesis and heterologous expression. Complementary DNA (cDNA) clones 
encoding the adult mouse-muscle AChR subunits (accession numbers: α1, P04756; β1, P09690; δ, 
P02716; ε, P20782) were provided by S.M. Sine (Mayo Clinic College of Medicine, Rochester, MN, USA); 
cDNAs for the rat GluA1-flip (accession number: P19490-2) and rat GluA2-flop (RNA-edited form, that is, 
containing the Q608R and R743G variants; accession number: P19491-1) AMPAR subunits by I. Greger 
(MRC Laboratory of Molecular Biology, Cambridge, UK); cDNAs for the rat GABAAR α1, β1 and γ2L 
subunits (accession numbers: α1, P62813; β1, P15431; γ2L, Q6PW52) by J. Fisher (University of South 
Carolina School of Medicine, Columbia, SC, USA); cDNA for the rat purinergic ionotropic type 2 receptor 
(P2X2R) (accession number: P49653) by A. Surprenant (University of Manchester, Manchester, UK); 
cDNA for the rat glycine receptor (GlyR) α1 subunit, isoform b (accession number: P07727-2) by M.M. 
Slaughter (University at Buffalo, Buffalo, NY, USA); and cDNA for the human GlyR β subunit (accession 
number: P48167) by P.R. Schofield (School of Medical Sciences, The University of New South Wales, 
Sydney, NSW, Australia). To convert the rat GlyR α1 subunit open reading frame into its human 
counterpart (accession number: P23415) we engineered the required mutations (F9L, D27E, D354E, 
G357A, N388S, A394P, and K449Q) using a QuikChange site-directed mutagenesis kit (Stratagene). 
cDNAs for the human AChR α3, α5 and β4 subunits were purchased from Open Biosystems (accession 
numbers: α3, P32297; α5: P30532-1; β4, P30926) and were subcloned into pcDNA3.1. The latter subunit 
cDNAs were cotransfected with cDNA encoding for human RIC-3 isoform 1 (accession number: Q7Z5B4-
1, provided by W.N. Green, University of Chicago, Chicago, IL, USA) a chaperone that appeared to 
enhance the expression of these AChRs in our experiments (as judged from the larger peak amplitudes 
of the recorded currents) in keeping with previous reports (Lansdell et al. 2005). Human embryonic 
kidney- (HEK) 293 cells were transiently transfected with cDNA using a calcium-phosphate precipitation 
method. 
 42 
 
2.2.2 Electrophysiology. Agonist-concentration jumps were applied to outside-out patches using a 
two-barreled glass-capillary “θ-tube” (Hilgenberg) through which two solutions flow, as described by 
Jonas (1995; see also Elenes et al. 2006, 2009). The θ-tube was mounted on a piezo-electric device 
(Burleigh-LSS-3100; Exfo), the movement of which was controlled using a Digidata 1322A interface and 
pClamp 9.0 software (both from Molecular Devices). To ensure smooth θ-tube movements, the 
computer-generated signals to the piezo-electric device were low-pass filtered (Frequency Devices 
900C) at a cutoff frequency between 125 and 150 Hz. The timecourse of solution exchange achieved 
with this system (t10–90% = 102 µs; t90–10% = 110 µs) was estimated by measuring the liquid-junction 
potential developed when alternately exposing the tip of an open patch pipette to a 1-M KCl solution 
(for ~1 ms) and a 140-mM KCl solution (for ~20 ms) flowing through the two barrels of the θ-tube, as 
described previously (Elenes et al. 2006). Ensemble (“macroscopic”) currents were recorded at –80 mV 
(unless otherwise indicated) and room temperature using an Axopatch 200B amplifier (Molecular 
Devices), and were digitized at 100 kHz; the effective bandwidth before analysis was DC–10 kHz. Single-
channel current–voltage (I–V) data were recorded in the cell-attached configuration at room 
temperature using an Axopatch 200B amplifier (Molecular Devices), and were digitized at 100 kHz; the 
effective bandwidth before analysis was DC–20 kHz. 
2.2.3 Solutions. For macroscopic-current recordings, outside-out patches were alternately exposed to 
two solutions differing only in the presence or absence of agonist. Apart from the agonist concentration, 
this solution consisted of (in mM) 142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, 10 HEPES/KOH, pH 7.4. The 
pipette solution consisted of (in mM) 100 KF, 40 KCl, 1 CaCl2, 11 EGTA, and 10 HEPES/KOH, pH 7.4. For 
cell-attached, single-channel recordings, we used the same solution in the patch pipette as in the bath, 
the only difference being the presence of agonist in the pipette. The composition of this solution was (in 
mM) 142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, 10 HEPES/KOH, pH 7.4. For every receptor, the natural 
neurotransmitter was used as the agonist; their concentrations were: 1 mM ACh, 1–10 mM GABA, 1–10 
mM Gly, 10 mM Glu and 0.85 mM ATP. 
2.2.4 Pulse protocols and data analysis. Macroscopic data were analyzed using pClamp 9.0 
(Molecular Devices) and SigmaPlot 7.101 (SPSS Inc.), whereas single-channel data were idealized using 
the SKM option in QuB software (Qin, 2004) (www.qub.buffalo.edu). To characterize the timecourse of 
deactivation, we applied short (1-ms) pulses of neurotransmitter at saturating concentrations in the 
form of low-frequency trains (for the P2X2R, we applied trains of 10 pulses at 0.125 Hz or trains of 25 
pulses at 1 Hz; for all other NGICs studied here, we applied trains of 25 pulses at 1 Hz). The responses to 
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individual pulses were averaged within each train (one train per patch), and these averaged traces were 
fitted with an exponential function from the peak of the transient through the end of any observable 
current. The resulting time constants were averaged across patches and are listed in Table 2.1. To 
characterize the timecourse of entry into desensitization, we applied long (2–5-s) applications of 
neurotransmitter at saturating concentrations. The resulting current traces were fitted with an 
exponential function from the peak of the transient through either the end of the agonist pulse or the 
end of any observable current (whichever came first). The resulting time constants were averaged 
across patches and are listed in Table 2.1. To characterize the timecourse of recovery from 
desensitization, we applied pairs of conditioning (1-s) and test (100-ms) pulses of neurotransmitter at 
saturating concentrations with agonist-free interpulse intervals of variable duration. The interval 
between any two consecutive pairs of pulses was adjusted for each receptor so as to ensure complete 
recovery from desensitization before application of each new conditioning pulse. The fraction of 
receptor channels that recovered at the end of each interpulse interval was calculated as the peak 
response to the test pulse minus the current at the end of the corresponding conditioning pulse divided 
by the difference between the peak response to the conditioning pulse and the current at the end of it. 
Plots of the fraction of recovered receptors as a function of the duration of the interpulse intervals were 
well fitted, in most cases, with mono-exponential-rise functions. The corresponding time constants are 
listed in Table 2.1. To characterize the response to repetitive stimulation, we applied trains of 1-ms 
pulses of saturating neurotransmitter at variable frequencies. High patch-to-patch variability 
complicated our analysis of macroscopic recordings. Quite notably, the number of exponential 
components that was deemed necessary to fit the macroscopic responses (as judged by visual 
inspection) varied from patch to patch for any given receptor (Table 2.2). 
2.2.5 Expression of heteromeric glycine and AMPA receptors. Both homomeric (α1) and heteromeric 
(α1β) GlyRs can form. To favor the expression of the heteromeric receptor, we transfected subunit 
cDNAs at a 40:1 β:α1 ratio, as suggested by Sivilotti and coworkers (Burzomato et al. 2004). Under these 
conditions, we observed only one burst of single-channel openings with a conductance corresponding to 
that of the α1-subunit homomer (105 ± 2 pS; all other bursts had a conductance of 54 ± 1 pS) out of 
>500 total bursts recorded in ten cell-attached patches. As is the case for the GlyRs, both homomeric 
(GluA1) and heteromeric (GluA1/2) AMPARs can form. Additionally, GluA2 homomers can also form, but 
the extremely low single-channel conductance of the Q/R RNA-edited form of these channels (the one 
we used here) prevents them from making an appreciable contribution to the macroscopic currents 
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(Swanson et al. 1997). To favor the expression of the heteromeric receptor, we transfected subunit 
cDNAs at a 10:1 GluA2:GluA1 ratio. To assess the validity of this approach, we generated macroscopic I– 
Table 2.1. Kinetic parameters of channel deactivation and desensitization 
aMean (  standard-error) values of time constants estimated as indicated in Methods. Where applicable, 
normalized amplitudes are shown in parentheses. All shown estimates correspond to recordings 
obtained from outside-out patches within 2 and 5 min upon attaining the whole-cell configuration 
(“early time” in Table 2.3). Considerable patch-to-patch variability was observed for the kinetics of 
deactivation and, especially, entry into desensitization at the level of both, time-constant/amplitude 
values and number of exponential components (see Table 2.2). For each receptor, the mean values in 
this Table correspond to those calculated by averaging the time-constant and amplitude estimates 
obtained only from the subset of traces that were best fitted with the most common number of 
components. 
 
V relationships in the presence or absence of spermine (a pore blocker of the homomeric, but not the 
heteromeric, channel (Kamboj et al. 1995)), in the pipette of outside-out patches. Figure 2.1 shows the 
NGIC τdeactivation (ms)
a τentry into desensitization (ms)
a τrecovery (ms) 
α1β1δε  AChR 1.11 ± 0.05 45.7 ± 9.94 (0.70 ± 0.08) 
516 ± 172 (0.30 ± 0.08) 
267 ± 11 
α1 GlyR 3.97 ± 0.77 (0.67 ± 0.06) 
23.1 ± 4.8 (0.33 ± 0.06) 
3.76 ± 1.37 (0.49 ± 0.07) 
77.5 ± 17.6 (0.22 ± 0.05) 
1,316 ± 400 (0.29 ± 0.04) 
476 ± 153 (0.39 ± 0.07) 
6,210 ± 880 (0.61 ± 0.07) 
α1β GlyR 4.90 ± 0.63 (0.61 ± 0.05) 
29.0 ± 3.5 (0.39 ± 0.05) 
5.54 ± 0.88 (0.24 ± 0.05) 
107 ± 16 (0.19 ± 0.04) 
3,833 ± 796 (0.58 ± 0.05) 
866 ± 277 (0.46 ± 0.11) 
6,420 ± 1,300 (0.54 ± 0.11) 
α1β1γ2L 
GABAAR 
2.94 ± 0.64 (0.67 ± 0.04) 
22.5 ± 8.26 (0.33 ± 0.04) 
 
2.56 ± 0.39 (0.60 ± 0.03) 
86 ± 26 (0.15 ± 0.03) 
2,569 ± 496 (0.25 ± 0.03) 
3,650 ± 170 
GluA1 AMPAR 0.57 ± 0.04 2.65 ± 0.17 214 ± 12 
GluA1/2 AMPAR 0.57 ± 0.07 2.10 ± 0.16 120 ± 11 
P2X2R 23.3 ± 2.6 (0.43 ± 0.05) 
85.8 ± 11.9 (0.57 ± 0.05) 
47.7 ± 6.1 (0.37 ± 0.04) 
378 ± 71 (0.63 ± 0.04) 
18,100 ± 1,380 
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block by spermine of, mostly, the outward currents through homomeric GluA1 receptors and the 
absence of blocking effect on the population of receptors expressed upon transfection with the 10:1 
GluA2:GluA1 cDNA mixture. We conclude that this ratio of cDNAs leads to the expression of mostly 
heteromeric GluA1/2 receptors in the membrane of HEK-293 cells. 
             
Figure 2.1. Effect of spermine on homomeric and heteromeric AMPARs. Normalized macroscopic I–V 
relationships estimated from outside-out patches in the absence or presence of spermine (100-µM) in 
the pipette. Patches were excised from HEK-293 cells transfected with different mixtures of AMPAR-
encoding cDNAs. A, GluA1-flip cDNA alone. B, A 10:1 mixture of cDNAs encoding the GluA2-flop and 
GluA1-flip AMPARs, respectively. The unbroken lines are cubic-spline interpolations. In these 
experiments, the reference Ag/AgCl wire was connected to the bath solution through an agar bridge 
containing 200-mM KCl, to minimize the liquid-junction potential. Liquid-junction potentials were 
calculated using the JPCalc module in pClamp 9.0 (Barry and Lynch, 1991). 
2.3 Results 
All known NGICs (including even their bacterial homologues (Gonzalez Gutierrez and Grosman, 2010)), 
can desensitize, that is, enter a set of non-conductive conformations that, when fully bound to ligand, 
become the most stable states of the channel (Magleby and Pallotta, 1981; Dilger and Liu, 1992; Franke 
et al. 1993; Elenes and Auerbach, 2002; Giniatullin et al. 2005). As elaborated in our previous work 
(Elenes et al. 2006, 2009), NGICs exposed to “synaptic-like”, repetitive applications of neurotransmitter 
can desensitize not only within but also between pulses, even if the clearance of neurotransmitter 
between pulses were complete and infinitely fast. During neurotransmitter pulses, the extent of 
desensitization is limited by the comparatively short lifetime of neurotransmitter in the synaptic cleft 
whereas, during the much longer interpulse intervals, entry into desensitization is limited by the fact 
that neurotransmitter dissociation provides an alternative route for channel deactivation. Despite these 
limitations, however, the fraction of channels that enter desensitized states upon repetitive stimulation 
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need not be negligible. Furthermore, because recovery from desensitization takes time, repeated 
exposure to neurotransmitter may lead to the progressive decline of the peak-current amplitudes. 
Table 2.2. Patch-to-patch variability in the number of exponential components required to fit 
macroscopic recordings.  
NGIC Kinetic parametera Number of 
exponential 
components 
Number of patches 
α1β1δε  AChR Deactivation 1 6 
2 2 
Entry into 
desensitization 
1 4 
2 7 
α1 GlyR Deactivation 2 5 
3 1 
Entry into 
desensitization 
2 3 
3 7 
4 3 
α1β GlyR Deactivation 2 14 
Entry into 
desensitization 
1 1 
2 4 
3 7 
α1β1γ2L GABAAR Deactivation 2 9 
3 6 
Entry into 
desensitization 
3 11 
4 6 
GluA1 AMPAR Deactivation 1 13 
Entry into 
desensitization 
1 15 
2 1 
GluA1/2 AMPAR Deactivation 1 6 
2 3 
Entry into 
desensitization 
1 9 
2 3 
P2X2R Deactivation 1 4 
2 10 
Entry into 
desensitization 
2 8 
aFor the analysis of the kinetics of recovery from desensitization, data recorded from different patches 
were pooled together (Figure 2.4E). As a result, the patch-to-patch variability of this kinetic parameter 
was not assessed. 
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The extent to which the peak currents decrease upon repetitive stimulation depends on the particular 
values of the rate constants governing the behavior of each channel, on the concentration of 
neurotransmitter, and on the frequency of the stimulus train. As a result, this decline could range from 
negligible to a situation in which only the first pulse in a train elicits a measurable current transient. 
Because the response of an NGIC to a train of stimuli cannot be easily inferred from the channel’s 
response to other types of ligand applications, we set out to determine the extent of this decline 
experimentally. 
Figure 2.2. Peak-current depression upon 
repetitive stimulation. A–G, Current traces 
recorded from individual outside-out patches. 
Each panel is the response of a different NGIC to 
the application of a 50-Hz train of 1-ms pulses of 
saturating neurotransmitter for 2 s. One such 
train is indicated in A above the current trace. 
The zero-current level is indicated with a dotted 
line. The concentration of neurotransmitter was 
1-mM ACh, 10-mM GABA, 10-mM Gly, 10-mM 
Glu and 0.85 mM-ATP for the AChR, the GABAAR, 
the GlyRs, the AMPARs and the P2XR, 
respectively. Although the responses recorded 
from individual patches exhibited high patch-to-
patch variability, the traces shown are 
representative of the average behavior of each 
receptor. We noticed that the individual current 
transients decay (during the interpulse intervals) 
with the same kinetics regardless of their relative 
position within a train of responses or of the 
frequency of the stimulation (tested range: 1–50 
Hz). Hence, we rule out the possibility that an 
incomplete agonist washout between 
consecutive neurotransmitter applications 
enhanced the observed extent of desensitization. 
The larger extent of desensitization observed for 
the muscle AChR compared to that reported 
earlier (Elenes et al. 2006; 2009) is likely due to 
the use of a higher concentration of ACh in the 
experiments reported here (1 mM instead of 100 
µM). 
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Figure 2.3. Time-dependent changes in the entry into desensitization timecourse. Pairs of entry into 
desensitization timecourses recorded from outside-out patches (a single patch per panel) in response to 
long pulses of saturating concentrations of neurotransmitter. All traces were normalized to their peak 
amplitudes. The two traces in each pair were recorded at different times upon obtaining the outside-out 
configuration; time was counted from the moment the whole-cell configuration was attained. The zero-
current level is indicated with a dotted line. In A, the early and late application times were 3.5 and 6.1 
min. In B, these were 4.5 and 8.8 min. In C, these were 2.8 and 6.8 min. In D, these were 2.7 and 13.2 
min. The concentration of ACh was 1 mM, and that of GABA or Gly was 10 mM. Values of the time 
constants of entry into desensitization at these two different time points were averaged across patches 
and are listed in Table 2.3. Very likely, the time-dependent changes illustrated here contribute to the 
large patch-to-patch variability commonly reported for the entry into desensitization kinetics of these 
and other NGICs (for example, Dilger and Liu, 1992; Franke et al. 1993). The entry into desensitization 
timecourses corresponding to the two AMPARs examined in this paper did not change appreciably with 
time, whereas those corresponding to the P2X2R did change but in a manner that was inconsistent from 
patch to patch; hence, the traces corresponding to these receptors are not shown. 
 
2.3.1 NGICs desensitize appreciably during deactivation 
Figure 2.3.1 shows representative responses of members of all three superfamilies of NGICs (namely, 
the Cys-loop, excitatory-glutamate and purinergic receptor channels) to trains of 1-ms pulses of 
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saturating neurotransmitter applied at 50-Hz, a physiologically relevant frequency. These channels are 
the mouse muscle, adult-type AChR, the rat α1β1γ2L GABAAR, the human α1 GlyR, the human α1β GlyR, 
the rat GluA1-flip AMPAR, the rat GluA1-flip / GluA2-flop AMPAR and the rat P2X2R. To avoid the 
ambiguities associated with the slow perfusion of whole cells (and thus, for example, to make sure that 
the concentration of neurotransmitter remains as close to zero as possible during most of each 
interpulse interval), we used fast-perfused outside-out patches (solution-exchange time ≅ 100 µs). To 
minimize the time-dependent changes in the kinetics of conformational transitions that, typically, 
accompany patch excision (Frosch et al. 1992; Lester and Dani, 1994; Mott et al. 2001) (Figure 2.3 and 
Table 2.3), the 50-Hz trains were applied within a narrow time window upon obtaining the outside-out 
patches, and only one such train was applied to any given patch of membrane. To ensure uniformity, all 
the receptors were subjected to the same stimulation protocols, the same expression system and the 
same saline solutions. Also, to gain a more complete understanding of the postsynaptic response to 
physiological trains of presynaptic action potentials, we applied several tens of neurotransmitter pulses 
with each train, not just pairs.  
 
Figure 2.4. Kinetics of channel deactivation and desensitization. A, Deactivation. Normalized current 
traces recorded from individual outside-out patches containing the indicated receptor channels. For 
each receptor, 25 consecutive responses to 1-ms pulses of saturating neurotransmitter applied as low-
frequency trains were averaged. The concentration of each neurotransmitter was as indicated for Figure 
2.2. The estimated kinetic parameters are listed in Table 2.1. B, Entry into desensitization. Normalized 
current traces recorded from individual outside-out patches upon stepping the concentration of 
neurotransmitter from zero to saturating. The colour code is the same as in A. The estimated kinetic 
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parameters are listed in Table 2.1. Although the responses recorded from individual patches exhibited 
high patch-to-patch variability, the traces shown in A and in B are representative of the average 
behavior of each receptor. C, Recovery from desensitization. The kinetics of recovery were estimated 
using pairs of conditioning (1-s) and test (100-ms) pulses of saturating neurotransmitter with interpulse 
intervals of variable duration. The colour code is the same as in A. Vertical error bars are standard errors 
calculated from the results of several independent experiments (one experiment per patch). The 
estimated time constants are listed in Table 2.1. The remarkably slow recovery from desensitization of 
the P2X2R very likely underlies this receptor’s pronounced depression even in response to low-frequency 
repetitive stimulation. 
 
 
As is clear from Figure 2.2, the peak responses of all studied receptors decline within the applied 50-Hz 
stimulus trains. Since the peak currents recover their full amplitude after prolonged exposure to 
neurotransmitter-free solutions (Figure 2.4), we rule out the possibility that mechanisms such as 
receptor internalization contribute to the observed fading of the current responses. Rather, we attribute 
Figure 2.5. Desensitization occurs 
mostly during the interpulse intervals. 
A, Response of an outside-out patch 
containing GluA1 AMPARs to the 
application of a 50-Hz train of 1-ms 
pulses of 10-mM Glu magnified so as to 
show only the first two current 
transients. The zero-current level is 
indicated with a black dotted line. The 
red dotted lines help distinguish the 
extent to which desensitization occurs 
during the 1-ms application of Glu 
(blue arrow) from that occurring in 
between applications (green arrow). 
Because desensitized receptors can 
recover during the interpulse intervals, 
the extent of desensitization is actually 
larger than that indicated by the green 
arrow. B, Response of an outside-out 
patch containing α1β1γ2L GABAARs to 
the application of a 50-Hz train of 1-ms 
pulses of 10-mM GABA. As in A, only 
the first two current transients are 
shown. Note that the extent of 
desensitization during the 1-ms pulse 
of GABA is negligible. 
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the observed phenomenon to receptor-channel desensitization. A closer inspection of the current traces 
in Figure 2.2 indicates that the depression of the peak current amplitudes cannot be accounted for by 
entry into desensitization during the ~1-ms neurotransmitter pulses, alone, (Figure 2.5) and that, 
instead, these NGICs must also desensitize during the interpulse intervals. Furthermore, the traces in 
Figure 2.2 show that the declining peak-current amplitudes within a train of responses tend to a steady-
state level consistent with the idea that the number of channels that accumulate in the desensitized 
state(s) eventually approaches the number of desensitized channels that recover. Also consistent with 
the entry into and recovery from desensitization phenomena, these steady-state values decrease as the 
train frequency increases (Figures 2.6 and 2.7), eventually becoming identical to the steady-state current 
elicited in response to the continuous application of neurotransmitter (Figure 2.8). 
Table 2.3. Changes in the kinetics of entry into desensitization estimated from outside-out patch 
recordings as a function of the time elapsed after attaining the whole-cell configuration. 
NGICa Early time 
(min)b 
Late time 
(min)b 
τentry into desensitization, early 
(ms)c 
τentry into desensitization, late 
(ms)c 
α1β1δε  AChR 3.31 ± 0.12 
(7) 
6.32 ± 0.32 
(5) 
45.7 ± 9.94 (0.70 ± 0.08) 
516 ± 172 (0.30 ± 0.08) 
21.4 ± 4.6 (0.81 ± 0.03) 
203 ± 88 (0.19 ± 0.03) 
α1 GlyR 3.00 ± 0.21 
(6) 
7.08 ± 1.00 
(4) 
3.76 ± 1.37 (0.49 ± 0.07) 
77.5 ± 17.6 (0.22 ± 0.05) 
1,316 ± 400 (0.29 ± 0.04) 
11.7 ± 6.1 (0.48 ± 0.06) 
86.0 ± 45.9 (0.18 ± 0.04) 
1,335 ± 495 (0.34 ± 0.03) 
α1β GlyR 2.43 ± 0.11 
(7) 
8.62 ± 1.69 
(4) 
5.54 ± 0.88 (0.24 ± 0.05) 
107 ± 16 (0.19 ± 0.04) 
3,833 ± 796 (0.58 ± 0.05) 
9.87 ± 3.07 (0.32 ± 0.07) 
191 ± 59 (0.36 ± 0.11) 
1,104 ± 256 (0.32 ± 0.10) 
α1β1γ2L 
GABAAR 
4.05 ± 0.24 
(8) 
8.18 ± 0.29 
(7) 
2.56 ± 0.39 (0.60 ± 0.03) 
86 ± 26 (0.15 ± 0.03) 
2,569 ± 496 (0.25 ± 0.03) 
4.52 ± 1.70 (0.43 ± 0.08) 
102 ± 41 (0.25 ± 0.05) 
694 ± 127 (0.32 ± 0.06) 
GluA1 AMPAR 3.98 ± 0.10 
(16) 
7.26 ± 0.22 
(11) 
2.65 ± 0.17 2.28 ± 0.12 
GluA1/2 AMPAR 3.94 ± 0.11 
(8) 
6.95 ± 0.15 
(7) 
2.10 ± 0.16 2.13 ± 0.36 
aChanges were observed for the P2X2R as well, but these were inconsistent across patches.  
bMean and standard errors. The number of analyzed experiments is indicated in parentheses (one 
experiment per patch). 
cMean and standard errors. Where applicable, normalized amplitudes are included in parentheses. 
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Figure 2.6. Frequency dependence of the rate and extent of depression. A–E, Normalized peak-current 
responses to trains of neurotransmitter pulses delivered at different physiologically-relevant 
frequencies. The colour code is the same as for Figure 2.4. The concentration of each neurotransmitter 
was as indicated for Figure 2.2. The number of trains averaged for each receptor–frequency 
combination ranged between 9 and 14. Only one train at any given frequency was applied per patch. 
Error bars are standard errors. The point corresponding to the first pulse in each train (black symbol) is, 
of course, the same for all trains. Using the steady-state peak response as a parameter, the rank order of 
depression upon 1-Hz stimulation is (from the lowest, most depressed steady-state response to the 
highest): P2X2R > α1β1γ2L GABAAR > α1 GlyR > α1β GlyR  GluA1 AMPAR  GluA1/2 AMPAR  α1β1δε 
AChR, whereas, upon 50-Hz stimulation, the order is: P2X2R > GluA1 AMPAR  α1 GlyR  α1β1γ2L 
GABAAR > GluA1/2 AMPAR  α1β GlyR  α1β1δε AChR. Using the peak response to the 10
th pulse of a 
50-Hz train as a parameter, the rank order is GluA1 AMPAR > GluA1/2 AMPAR  α1β1γ2L GABAAR  α1 
GlyR  P2X2R > α1β1δε AChR > α1β GlyR. 
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To gain a more quantitative understanding of the extent to which desensitization occurs within and 
between neurotransmitter pulses, we calculated the responses to repetitive stimulation of two example 
NGICs with widely different kinetics (Figure 2.4 and Table 2.1): the P2X2R and the muscle AChR. To this 
end, we applied Q-matrix methods (Colquhoun and Hawkes, 1995) to established kinetic models (Figure 
2.9A, B) of these two NGICs (Figure 2.10). These calculations, in which the application and removal of 
neurotransmitter were modeled as being infinitely fast, amply confirm the notion derived from Figure 
2.5. That is, that desensitization upon high-frequency stimulation occurs, to a large degree, when the 
concentration of neurotransmitter is essentially zero. 
2.3.2 Extent of receptor saturation 
The fraction of postsynaptic receptors that interact with the neurotransmitter released upon arrival of a 
presynaptic action potential, commonly referred to as the “extent of saturation”, is not necessarily unity 
(Clements, 1996; Frerking and Wilson, 1996; Xu-Friedman and Regehr, 2004). As a result, the mean 
frequency at which each individual postsynaptic receptor interacts with neurotransmitter may be only a 
Figure 2.7. Frequency 
dependence of depression. 
Normalized peak responses to 
trains of neurotransmitter pulses 
delivered at different 
physiologically-relevant 
frequencies. Error bars are 
standard errors. The point 
corresponding to the first pulse in 
each train (black symbol) is the 
same for all trains. The data in all 
seven panels were re-plotted from 
Figure 2.6. The colour code is: 1 
Hz, blue; 5 Hz, purple; 10 Hz, 
green; 25 Hz, cyan; and 50 Hz, red. 
The concentration of each 
neurotransmitter was as indicated 
for Figure 2.2. 
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fraction of the frequency of the incoming train of action potentials. Because the extent of depression 
decreases as the train frequency is reduced (Figures 2.6 and 2.7), one can expect that the lower the 
extent of saturation, the lower the degree of depression owing to desensitization. 
 
 
  
In our experiments, the relative diameters of the patch-pipette and the perfusion-pipette openings 
ensure that all the channels in the patch interact with neurotransmitter every time a pulse is applied. As 
a result, our experimental approach provides an upper-limit estimate of the extent of depression. To 
visualize with numerical examples how the extent of receptor saturation would affect the extent of 
depression, we calculated the expected responses of two NGICs to repetitive, 50-Hz stimulation (Figure 
2.11). These channels are the wild-type AMPAR (Figure 2.9C) and a hypothetical muscle-AChR mutant 
having a gating equilibrium constant that is larger than the wild-type’s by a factor of 10 (not an 
uncommon value for an AChR gain-of-function mutant) so as to accentuate the fading of the peak 
responses (Elenes et al. 2006, 2009). 
 
 
 
Figure 2.8. Responses to high-frequency, 
repetitive versus continuous application 
of neurotransmitter. Normalized current 
traces recorded from individual outside-
out patches upon the repetitive (50-Hz 
trains of 1-ms pulses; blue) or continuous 
(red) application of saturating 
neurotransmitter. For each receptor, both 
responses were recorded from the same 
patch. A, α1β1γ2L GABAAR; [GABA] = 10 
mM. B, α1 GlyR; [Gly] = 10 mM. C, α1β 
GlyR; [Gly] = 10 mM. D, P2X2R; [ATP] = 
0.85 mM. For these four NGICs, the 
responses to 50-Hz stimulation 
superimpose very well with the responses 
to long pulses of neurotransmitter. For the 
α1β1δε AChR and the AMPARs, even 
higher frequencies would be needed for 
the two types of response to converge. 
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Figure 2.9. Kinetic models used for Q-matrix calculations. “A” denotes a molecule of bound 
neurotransmitter, whereas “C”, “O” and “D” denote the closed, open and desensitized conformations of 
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the channel, respectively. Neurotransmitter-association rate constants are given in units of µM–1s–1; all 
other rate constants are given in units of s–1. A, A model of the adult-muscle, α1β1δε AChR. The values 
of the rate constants of ACh association to and dissociation from the open-channel conformation, as 
well as those between unliganded and mono-liganded open and closed states, are poorly defined, and 
our numbers are only tentative. However, changing any of these values by an order of magnitude in 
either direction does not appreciably affect the calculated responses to repetitive stimulation. The 
calculated timecourse of deactivation was best fitted with a time constant of 0.99 ms, whereas the 
experimentally-recorded timecourse was best fitted with a time constant of 1.11 ms (Table 2.1). The 
calculated timecourse of entry into desensitization was best fitted with a single-component exponential 
function with a half-time of 53.8 ms, whereas the experimentally-recorded double-exponential 
timecourse has a half-time of 51.2 ms (Table 2.1). B, A model of the P2X2R. This model (without the 
desensitized state, DA3) was originally proposed by Ding and Sachs (1999b), and modifications to the 
originally proposed set of rate-constant values were suggested by Moffatt and Hume (2007). Q-matrix 
calculations using the latter set of values matched our experimental observations quite closely, but an 
even better agreement with the responses to repetitive stimulation was obtained upon increasing the 
three ATP-association rate constants by a factor of 10. A desensitized state was added to the model with 
rate constants of entry and recovery calculated from our own experimental results. The asterisks in CA3
* 
and OA3
* indicate alternative conformations of the closed and open triply-liganded states. We note that 
the unusually fast rate constant from OA3 to CA3
* could be reduced by a factor of 104 without 
qualitatively affecting the calculated responses to repetitive stimulation. Also, the cycle of triply-
liganded states does not obey the principle of detailed balance, a feature we can neither confirm nor 
disprove with our experimental data. Although other kinetic models have been proposed to provide a 
better description of this channel’s behavior (Moffatt and Hume, 2007), the model in B seemed 
adequate for our purposes. The calculated timecourse of deactivation was best fitted with a single-
component exponential function with a half-time of 30.2 ms, whereas the experimentally-recorded 
double-exponential timecourse has a half-time of 32.2 ms (Table 2.1). The calculated timecourse of 
desensitization was best fitted with a single exponential function with a half-time of 119 ms, whereas 
the experimentally-recorded double-exponential timecourse has a half-time of 114 ms (Table 2.1). For 
both the muscle AChR and the P2X2R, recovery from desensitization during the neurotransmitter-free 
interpulse intervals was modeled as a single-step transition (dashed arrow) between the fully-liganded 
desensitized state and the unliganded closed state even when several individual steps of 
neurotransmitter dissociation and conformational change clearly must occur. This simplification is 
justified, however, because the timecourse of recovery in the absence of free neurotransmitter was well 
approximated by a single-component exponential function for these two channels (Figure 2.3.3C) and 
because the values of the rate constants governing the individual steps between DAn and C are not 
known. Another simplification is the inclusion of a single fully-liganded desensitized state even though 
these channels are very likely to adopt multiple desensitized conformations (for example, see Elenes and 
Auerbach, 2002). All of these simplifications, however, do not affect our general conclusion that the 
extent to which channels desensitize between neurotransmitter pulses is comparable to, if not larger 
than, that occurring during neurotransmitter pulses. C, A model of the GluA1 receptor taken from the 
work of Robert and Howe (2003). The calculated timecourse of deactivation was best fitted with a time 
constant of 0.92 ms, whereas the experimentally-recorded timecourse was best fitted with a time 
constant of 0.57 ms (Table 2.1). The calculated timecourse of desensitization was best fitted with a time 
constant of 1.91 ms, whereas the experimentally-recorded timecourse was best fitted with a time 
constant of 2.65 ms (Table 2.1). 
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The calculations for Figure 2.11 were done as for Figure 2.10, applying Q-matrix methods (Colquhoun 
and Hawkes, 1995) to established kinetic models with the added feature that only a fraction of the total 
population of channels was allowed to interact with the neurotransmitter (and thus, to desensitize) 
every time the response to a pulse of neurotransmitter was calculated. This fractional value (which we 
denote, here, as “p”) was kept constant throughout each train and represents the extent of receptor 
saturation. The calculations for Figure 2.11 were performed in such a way as to mimic the opening of a 
random subset of channels with every pulse of neurotransmitter. 
 
Figure 2.10. Open- versus desensitized-
state occupancies. Calculated timecourses 
corresponding to the P2X2R and the 
α1β1δε AChR in response to 50-Hz trains 
of 1-ms pulses of saturating 
neurotransmitter. The calculations were 
done by applying Q-matrix methods 
(Colquhoun and Hawkes, 1995) to 
established kinetic models of these two 
channels (Figure 2.7A and B). The 
occupancy of the open state (blue lines) 
includes the occupancies in all open 
states, regardless of their degree of 
ligation. A and B, P2X2R; [ATP] = 0.85 mM. 
In B, the timecourse during the first 20 ms 
(corresponding to the first pulse of 
neurotransmitter and the first interpulse 
interval) is shown at an expanded time 
scale. The vertical dashed line denotes the 
end of the 1-ms pulse. The colour code is the same for all panels. C and D, α1β1δε AChR; [ACh] = 1 mM. 
In D, the timecourse during the 20-ms interval corresponding to the tenth pulse of neurotransmitter and 
its corresponding interpulse interval is shown at an expanded time scale. The vertical dashed line 
denotes the end of the 1-ms pulse. The inset is a further magnified view of the data in the green 
rectangle. Panels A and C show how these channels accumulate in the desensitized state along trains of 
stimuli. Panels B and D show that a large fraction of this desensitization takes place while the 
neurotransmitter concentration is zero. 
 
As shown in Figure 2.11B and D, lower saturation values attenuate the extent of depression for both 
kinetic models but, as shown in Figure 2.11A and C, the peak-values of the currents calculated for lower-
saturation, less-depressing synapses never exceed those from synapses with higher extents of 
saturation. Clearly, at least for the two kinetic models examined here, reducing the extent of depression 
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by decreasing receptor saturation would not convert a failing synapse into a reliable one, even when the 
depression could be much less pronounced. 
 
Figure 2.11. Effect of extent of 
receptor saturation on depression. 
A, Calculated macroscopic currents 
through the wild-type GluA1 AMPAR 
in response to 50-Hz trains of 1-ms 
pulses of (saturating) 10-mM Glu. 
The kinetic model in Figure 2.9C was 
used. “p” represents the extent of 
saturation. The colour code is the 
same for all panels. B, Normalized 
peak responses calculated from the 
data in A. The point corresponding 
to the first pulse in each train (black 
symbol) is the same for all trains. C, 
Calculated macroscopic currents 
through a hypothetical gain-of-
function mutant of the α1β1δε AChR 
in response to repetitive stimulation, 
as in A. The (saturating) 
concentration of ACh used for this calculation was 1 mM. The only difference with the kinetic model of 
the wild-type muscle AChR in Figure 2.9A is that the diliganded gating equilibrium constant was 
increased by a factor of 10 (by slowing down the corresponding closing rate constant while keeping the 
opening rate constant unchanged) so as to increase the extent of depression (Elenes et al. 2006, 2009). 
To maintain detailed balance, the gating equilibrium constants of the un- and monoliganded receptors 
were also increased by a factor of 10 by, in this case, speeding up the corresponding opening rate 
constants. It is important to realize, however, that the precise way in which these changes in equilibrium 
constants are brought about by changes in the underlying forward and backward rate constants has a 
negligible effect on the calculated currents and is, hence, irrelevant to our conclusions. D, Normalized 
peak responses calculated from the data in C. 
 
It is worth noting here that most estimates of NGIC saturation in intact synapses are closer to unity than 
they are to zero (Clements et al. 1992; Faber et al. 1992; Tong and Jahr, 1994; Auger and Marty, 1997; 
Harrison and Jahr, 2003). Therefore, the fact that the channel responses studied here (Figure 2.3.1, for 
example) were recorded under conditions of full saturation is not be a major concern. 
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2.4  Discussion 
In this study, we investigated the postsynaptic mechanisms of short-term plasticity in detail. Thus, our 
priority was to maximize the accuracy of the electrophysiological recordings and to eliminate variables 
that could lead to ambiguities in their interpretation. To accomplish this goal, we chose to use fast-
perfused outside-out patches from transiently-transfected cells and showed that all studied channels 
desensitize upon repetitive stimulation to an appreciable degree. To our knowledge, this is the first time 
the current responses of members of all three superfamilies of NGICs to a synaptic-like application of 
neurotransmitter were recorded under identical experimental conditions, thereby allowing the direct 
comparison of their behaviors. Furthermore, for some of these channels, this might be the first time that 
their response to long trains of high-frequency stimulation was recorded at all. 
Of course, it could be argued that the relevant auxiliary proteins and post-translational modifications 
that occur in native postsynaptic membranes are unlikely to be present in a heterologous expression 
system such as HEK-293 cells. It is precisely for this reason that our results should be regarded as a 
starting point that defines the behavior of these channels in a sort of “basal” or “minimal” state. Future 
work will have to address the functional impact of ancillary proteins and chemical modifications, 
although these interactions remain largely unknown for most NGICs. It could also be argued that 1-ms 
pulses are much longer than typical exposure times to neurotransmitter in the context of a synapse, but 
our finding that desensitization occurs, to a large degree, between pulses (as opposed to within pulses) 
should lessen this concern. In summary, to the extent that our experimental approach recapitulates the 
most important aspects of NGIC function at the postsynaptic membrane, our results clearly indicate that 
channel desensitization has the potential to contribute to short-term depression much like well-studied 
presynaptic mechanisms, such as vesicle depletion, can. By no means, however, do we mean to imply 
that desensitization will necessarily lead to synaptic transmission failure. Whether the depression of the 
peak-current amplitudes leads or does not lead to the interruption of the flow of action potentials 
ultimately depends on the properties of each particular synapse. For example, in normal human 
subjects, detailed electrophysiological studies (Bigland-Ritchie et al. 1982) indicate that synaptic 
transmission at the neuromuscular junction rarely fails even during extreme exertion whereas, at least 
in some glutamatergic synapses, channel desensitization upon high-frequency stimulation has been 
proposed to have behavioral consequences (Trussell, 1999; Chanda and Xu-Friedman, 2010). At fast 
chemical synapses mediated by other neurotransmitters, on the other hand, the relationship between 
desensitization and synaptic transmission failure has been investigated in much less detail. 
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Another conclusion that follows from our results is that an incomplete clearance of neurotransmitter 
from the synaptic cleft between vesicle-fusion events need not be invoked to account for NGIC 
desensitization upon repetitive stimulation. Certainly, our data show that, for all tested NGICs, entry 
into desensitization contributes to the timecourse of deactivation (that is, the decay of the current in 
the complete absence of agonist). Evidently, if neurotransmitter removal were slower or less complete 
than that under our experimental conditions (as is likely to be the case, at least, for some synapses), 
then channel desensitization and the ensuing decline of the peak-current amplitudes would be even 
more pronounced. 
Finally, we also conclude that any descriptions of the behavior of NGICs and their mutants in terms of 
rate constants of kinetic schemes need to account for the (often ignored) desensitization phenomenon. 
Indeed, the notion that desensitization contributes to shape the deactivation timecourse indicates that 
even single-channel events recorded at very low concentrations of neurotransmitter could be 
misinterpreted in terms of mechanisms if desensitization were disregarded. 
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Chapter III – On the irreversible depression of α3β4 AChRs2 
α3-containing nicotinic acetylcholine receptors (AChRs) are expressed in autonomic ganglia, where they 
mediate fast synaptic transmission. These receptors have largely eluded rigorous kinetic characterization 
due to a combination of poor expression in heterologous systems and the irreversible loss of receptor 
responsiveness (known as channel “rundown”) during the course of excised-patch electrophysiology 
experiments. Recently, it was suggested that a cysteine-to-alanine mutation at the –4’ position of the 
cytosolic M1-M2 linker prevents rundown in whole-cell recordings from rodent superior cervical 
ganglion neurons (Campanucci et al., 2010). This work also suggested that the rundown, which is 
proposed to play a pivotal role in diabetic neuropathy, is due to the oxidation of the cysteines at 
position –4’. In this Chapter, we discuss work in which we heterologously expressed human α3-subunit-
containing AChRs in HEK-293 cells and found that mutation of the –4’ cysteine to alanine does not 
prevent the irreversible rundown of currents observed in outside-out patches of membrane. We also 
find that the irreversible loss of responsiveness in excised patches is not due to lost actin-channel 
interactions or receptor density dependent effects. Overall, our results suggest that the mechanism 
underlying the rundown of currents mediated by α3-containing AChRs in outside-out patches is 
fundamentally different from that proposed to be mediated by cysteine oxidation in whole-cell 
recordings. They also suggest that the mechanism of oxidation-modulation of AChR function is more 
complex than previously thought. 
                                                          
2
 Portions of this Chapter are adapted from Papke et al., 2011 (Journal of Physiology, 2011, 589, 1571-1585) 
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3.1 Introduction 
Cysteine oxidation has been implicated in regulation of many channels, including the large-conductance 
calcium-activated potassium channel (BKCa), the hERG1 potassium channel, and the α3β4 acetylcholine 
receptors (AChRs) (Tang et al., 2001; Kolbe et al., 2010; Krishnaswamy and Cooper, 2012). In the case of 
the α3β4 AChRs, oxidation of the –4’ cysteine, located in the cytosolic M1-M2 loop, has been reported 
to cause an irreversible loss of responsiveness (known as “rundown”) of receptors in superior cervical 
ganglion (SCG) neurons (Campanucci et al., 2008; Campanucci et al., 2010). This rundown is a medically 
relevant phenomenon, having been proposed to underlie the pathophysiology of diabetic neuropathy 
(Krishnaswamy and Cooper, 2012), a condition in which a boost in cytosolic reactive oxidative species 
leads to increased cysteine oxidation (Baynes, 1991). It is unclear whether the reported oxidation of the 
cysteine at position –4’ stabilizes a normally accessible desensitized state, or whether it leads to a 
structurally distinct non-conductive conformation; in either case, entry into this state compromises the 
responsiveness of α3β4 receptors (Campanucci et al., 2010). 
Channel rundown has also been observed in the responses of α3β4 AChRs to agonist in excised patches 
of membrane (Nelson and Lindstrom, 1999), but not in the whole-cell configuration (for example, 
Krashia et al., 2010; Papke et al., 2010). This patch-clamp configuration dependent, long-lived non-
conductive state has greatly complicated attempts to rigorously characterize α3β4 AChRs using 
concentration jumps in fast-perfused outside-out patches. Indeed, the receptor opens in response to 
only one or two pulses of ACh before completely losing the ability to further respond (Papke et al., 
2011). 
Determination of the mechanism behind this irreversible loss of responsiveness is likely to be an 
important step in gaining a full understanding of the physiological function of α3β4 AChRs; in fact, 
similar configuration-dependent behavior has given insight into the function of other channels under 
their normal physiological conditions. For example, a loss of responsiveness in excised patches was 
observed for the cold- and menthol-sensitive TRPM8 receptor (Reid and Flonta, 2002; Voets et al., 2004; 
Liu and Qin, 2005) and several potassium channels, including the Kir 2.1 (Rohács et al., 1999; Lopes et 
al., 2002) and the KCNQ channels (Loussouarn et al., 2003; Li et al., 2005). For all of these receptors, it 
was found that the rundown resulted from the loss of a PIP2-channel interaction, owing to the absence 
of phosphokinases in excised patches (Liu and Qin, 2005). Thus, investigation into phenomena similar to 
the rundown of α3β4 AChRs has led to important physiological findings, amply justifying our interest in 
understanding what causes the rundown of α3β4 ganglionic receptors in excised patches of membrane. 
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In light of the work of Campanucci et al., the aberrant behavior of α3β4 AChRs in outside-out patches is 
potentially related to the behavior of these receptors in diabetic neuropathy. Here, we investigate the 
effect of cysteine oxidation, as well as actin cytoskeleton disruption, phosphatidylinositol 4,5-
bisphosphate (PIP2) depletion and receptor density, on the function of α3β4 AChRs in the outside-out 
and whole-cell configurations. We find that none of the investigated modulatory mechanisms (cysteine 
oxidation, PIP2 depletion, receptor density, and actin-cytoskeleton interactions) is individually 
responsible for the irreversible depression recorded in outside-out patches, implying that the oxidation-
modulated depression in autonomic ganglia and the depression observed in outside-out patches are 
mechanistically distinct. Finally, we engineered a series of point mutations at the –4’ position of the 
α3β4 receptor and measured their effect on function in the whole-cell configuration. Because these 
constructs exhibited only modest differences in behavior relative to the wild-type, we arrive at the 
conclusion that the effect of cysteine oxidation described in SCG neurons (Campanucci et al., 2010) 
cannot be mimicked by point mutations. Ultimately, our results imply that the mechanism of cysteine-
oxidation modulation of α3β4 AChRs might be less straightforward than originally thought. 
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3.2 Methods 
3.2.1 cDNA clones, mutagenesis and heterologous expression 
cDNA encoding the human AChR α3, α5 and β4 subunits (accession numbers: α3, P32297; α5: P30532-1; 
β4, P30926) was purchased from Open Biosystems and was subcloned into pcDNA3.1. cDNA encoding 
the α3 and β4 AChR subunits was always transfected along with cDNA encoding RIC-3 isoform 1 
(accession number Q7Z5B4-1, provided by W.N. Green, University of Chicago, Chicago, IL, USA), a 
chaperone that appeared to increase expression of these AChRs in our experiments, consistent with 
previous reports (Lansdell et al., 2005; Treinin, 2008). All mutant constructs were generated using the 
QuikChange site-directed mutagenesis kit, and for each construct, the entire subunit-coding region of 
the cDNA was sequenced to confirm the presence of the desired mutations and the absence of 
unwanted ones, using the sequencing services of ACGT, Inc. (ACGT Inc., Wheeling, IL). 
All experiments were performed using HEK-293 cells, which were transiently transfected with subunit-
coding cDNA using a calcium phosphate precipitation method. After the 18 hour transfection was 
complete, cells were bathed in Dulbecco’s Modified Eagle Medium (Invitrogen, Cat No. 12100-046) prior 
to experimentation. Electrophysiological recording was performed between 24 and 54 hours after the 
end of the transfection. 
3.2.2 Electrophysiology 
Outside-out patches were positioned opposite a double-barreled “θ-tube” (Hilgenberg, Malsfeld, 
Germany) that was used to apply concentration jumps (Jonas, 1995; Elenes et al., 2006). Constant 
gravity-driven perfusion was applied to the bath during experiments to wash away agonist that might 
otherwise accumulate in the system. Solution flow through the θ-tube was controlled using a pressure-
driven valve system (ALA BPS-8; ALA Scientific Instruments, Farmingdale, NY, USA). The θ-tube 
movements were driven using a piezo-electric arm (Burleigh-LSS-3100; Lumen Dynamics Group Inc., 
Mississauga, Canada), controlled by pCLAMP 9.0 software and a Digidata 1322A interface (Molecular 
Devices, Sunnyvale, CA, USA). Signals from this interface were low-pass filtered (900C, Frequency 
Devices, Ottawa, IL, USA) at a cutoff frequency of 150 Hz prior to reaching the piezoelectric arm, to 
reduce ringing in the θ-tube motion. This system achieved a solution exchange time of 97 µs for the t10-
90% and 101 µs for the t90-10%, as estimated from changes in the liquid-junction potential measured with 
an open-tip patch pipette. All currents were recorded at –80 mV. 
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Whole-cell recordings were performed with the same system that was used in outside-out patches. In 
these recordings, cells were mounted in the fast-perfusion chamber, and the θ-tube was lowered so as 
to directly apply agonist to the patched cell at the bottom of the chamber. During recordings, all cells 
were perfused with the background perfusion solution described below. Series resistance and whole-cell 
capacitance corrections were performed using the Axopatch 200B amplifier (Molecular Devices). Series 
resistance compensation was set to 80% during all macroscopic recordings. The solution exchange times 
(t10-90% and t90-10% ) for this configuration, as estimated from the change in the liquid junction potential at 
the tip of the pipette, were found to be between 0.5 ms and 1 ms. Of course, the solution exchange time 
for the entire surface of the cell is, undoubtedly, slower.  
All concentration-jump patch-clamp recordings (whole-cell and outside-out) were made using an 
Axopatch 200B amplifier (Molecular Devices), with the signal digitized at 100 kHz, and with an effective 
bandwidth of DC–10 kHz. Data were acquired and analyzed using pCLAMP 9.0 software. 
3.2.3 Pulse protocols  
To estimate the time constants of entry into desensitization in the outside-out and whole-cell 
configurations, long, continuous pulses of 1-mM ACh (2-s for outside-out and 5-s for whole-cell) were 
delivered to the membrane, and the resulting traces were fit with exponential-decay functions. To 
obtain the time constants of deactivation in the outside-out configuration, a 1-Hz train consisting of 25 
1-ms pulses was delivered to the membrane. For constructs other than the α3β4 AChR, the responses to 
each pulse in the train were averaged, and the resulting traces were fitted with an exponential-decay 
function to estimate the time constants. In the case of the α3β4 AChRs, the extreme depression of peak 
responses even at a frequency as low as 1 Hz called for a different averaging strategy; with these 
receptors, only the first few peak responses to the pulse trains were averaged. In the whole-cell 
configuration, deactivation was again determined by averaging the peak responses to low frequency 
trains of pulses. However, here, the pulses were 200 ms in duration, owing to our inability to deliver 
shorter pulses to the entire cell membrane; the frequencies of these trains were not faster than 0.5 Hz. 
To determine the extent of rundown in the whole-cell configuration, 5-s pulses were applied every 2 
minutes to the cell, and peak responses were normalized to the amplitude of the initial response.  
Paired-pulse protocols were employed to assess recovery from desensitization. For the whole-cell and 
outside-out configurations, the initial, “conditioning” pulse was applied for 2 s. After an interpulse 
interval of variable duration, a shorter test pulse (lasting 200 ms for whole-cell recordings and 100 ms 
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for outside-out patches) was applied. The fraction of receptors recovered for a given interpulse interval 
was estimated by dividing the number of receptors desensitized by the conditioning pulse (the peak 
current of the conditioning pulse minus the current level at the end of the conditioning pulse) by the 
current recovered in the test pulse (the peak current of the test pulse minus the current level at the end 
of the conditioning pulse). These fractions were averaged across patches and plotted as a function of 
the duration of the interpulse interval. The resulting plots were fitted with exponential functions to 
estimate the time constants of recovery from desensitization. 
3.2.4 Solutions 
During recordings, cells were bathed in Dulbecco’s phosphate buffered saline (PBS; Invitrogen Cat. No. 
21300-025). For all mutagenesis experiments, the patch pipette contained, in mM: 100 KF, 40 KCl, 1 
CaCl2, 11 EGTA, and 10 Hepes/KOH at pH 7.4. The background perfusion consisted of, in mM: 142 KCl, 
5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, and 10 Hepes/KOH, at pH 7.4. Both barrels of the θ-tube contained 
background perfusion solution; in one barrel, agonist was added to this solution. 
3.2.5 Phalloidin staining procedure  
HEK-293 cells, seeded on coverslips and transfected with cDNAs encoding RIC-3 and the α3 and β4 
subunits, were first incubated in either Dulbecco’s phosphate buffered solution (PBS – Invitrogen) or PBS 
containing 10 µM latrunculin B (LatB – Sigma), for 1 h at 37 °C (all subsequent steps were performed at 
room temperature). Next, the cells were fixed in 1% formaldehyde/HBS (Hepes buffered saline, which is 
composed of 150 mM NaCl/20 mM HEPES), pH 7.8, for 30 min. The reaction was then quenched with 
100 mM glycine and 0.1% Triton X-100 detergent in HBS for 1 h. Cell membranes were permeabilized 
using HBS containing 0.5% Triton X-100 detergent for 10 min. After permeabilization, the cells were 
bathed in HBS containing 50 nM tetramethylrhodamine (TMR)-phalloidin and 1 µg/mL 4',6-diamidino-2-
phenylindole (DapI) for 15 min. Finally, the cells were washed with HBS for 10 min, and then mounted to 
slides using ProLong Gold antifade reagent (Invitrogen) for microscopy, which was performed 18 h after 
mounting. 
3.3 Results and discussion 
3.3.1 α3-containing AChRs in outside-out patches 
Initially, we intended to include the α3β4 AChR (often regarded as the main contributor to the α-
bungarotoxin-insensitive component of the postsynaptic ganglionic currents) in the study presented in 
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Chapter II, and thus, to subject it to the same protocols of pulses that were applied to all other NGICs. 
However, we found that the rise time of the currents through this AChR is too slow for appreciable 
currents to develop during 1-ms ACh pulses, which prompted us to prolong the pulses to 5 ms (Figure 
3.1). Furthermore, we found that the peak responses decline upon repetitive stimulation much more 
profoundly for the α3β4 AChR than for any of the channels discussed in Chapter II, to the point that we 
could only run a single stimulation protocol per patch of membrane. Whether shorter ACh pulses (closer 
in duration, perhaps, to the ACh transients in intact autonomic ganglia) reduce the fraction of AChRs 
that desensitize by virtue of their activating fewer channels remains to be ascertained. Our attempts so 
far to address this question have been hampered, however, by the profound decline of the currents, 
which precludes the repetitive application of pulses of different duration to the same patch of 
membrane. 
 
Figure 3.1. The α3β4 AChR and the effect 
of the α5 subunit. Normalized current 
traces recorded from individual outside-
out patches excised from cells transfected 
with human α3 and β4 (red) or human α3, 
β4 and α5 (blue) AChR-subunit cDNAs. 
Currents were elicited by the application 
of a 1-Hz train of 5-ms pulses of 1-mM 
ACh. The trace shown in red is 
representative of all the recordings 
obtained from cells transfected with a 
α3:β4 1:1 cDNA mixture. The trace shown in blue, however, is representative of only a minor fraction of 
the recordings obtained from cells transfected with a α3:α5:β4 1:1:1 cDNA mixture; the rest of these 
recordings were indistinguishable from those obtained with the α3-β4 mixture alone. The stimulus train 
is indicated above the current traces. Further applications of 1-mM ACh pulses to patches of membrane 
containing α3β4 AChRs elicited no response, even after prolonged, several-minute long incubations in 
the absence of ACh. 
 
As a step toward elucidating whether co-assembly of the α3 subunit with other subunits known to be 
part of ganglionic AChRs can give rise to receptors that respond more reliably to trains of ACh, we added 
cDNA encoding for the α5 subunit (Vernallis et al. 1993) to the α3-β4 cDNA transfection mixture. As 
judged from the higher single-channel conductance and shorter mean duration of the recorded bursts of 
openings, we conclude that the α5 subunit became successfully incorporated into functional AChRs. 
Indeed, bursts of openings of the sort recorded from cells transfected with the α3-β4 cDNA mixture 
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alone were only infrequently observed. In most patches, however, the incorporation of the α5 subunit 
did not affect the responses of outside-out patches to repetitive stimulation, inasmuch as the peak 
currents also declined irreversibly along low-frequency trains of 1-mM ACh. In a few patches, however, 
the currents did maintain a rather constant peak amplitude throughout the 1-Hz stimulation protocol 
(Figure 3.1), a behavior that more closely resembles the response of most other NGICs at this low 
frequency (see Figure 2.3.1 in Chapter II).  
Of all eight receptor channels studied in this work (the seven in Chapter II and the α3-containing AChRs), 
the α3 subunit-containing AChRs were the only ones whose responsiveness to neurotransmitter was lost 
in a seemingly irreversible manner upon repeated application of ligand. Such a strongly depressing 
response to low-frequency repetitive stimulation (1-Hz in Figure 3.1) is surprising for a receptor thought 
to mediate fast synaptic transmission in autonomic ganglia, but our finding is not entirely unexpected 
given the well-known rundown seen in excised patches (Nelson and Lindstrom, 1999).  
Other attempts to characterize the α3β4 AChRs have also been hampered by the irreversible rundown 
of the receptors in excised patches (Sivilotti et al., 1997; Nelson and Lindstrom, 1999). However, no 
explanation for the loss of function has been found. In Figure 3.2, we show that these receptors exhibit 
strikingly different behavior in the outside-out and whole-cell configurations: in the whole-cell 
configuration, receptors are able to recover from desensitization, like a typical neurotransmitter-gated 
ion channel (Figure 3.2A). However, Figure 3.2B shows that, in the outside-out configuration, peak 
currents undergo profound depression in response to series of brief (5-ms) neurotransmitter pulses. 
Furthermore, once α3β4 AChRs enter this long-lived non-conductive state in outside-out patches, they 
do not recover, even after neurotransmitter-free intervals lasting many minutes (Figure 3.2C).  
One possibility is that patch excision stabilizes the desensitized state such that, once receptors 
desensitize, it is not thermodynamically favorable for them to recover (throughout this Chapter, the 
“desensitized state” is used to refer to the set of long-lived, non-conductive conformations that are the 
most stable fully liganded states; Franke et al., 1993; Elenes and Auerbach, 2002). Such a stabilization 
could explain the irreversible depression seen in Figure 3.2B, since desensitization is known to occur in 
response to short pulses for all neurotransmitter-gated ion channels (Elenes et al., 2006; Elenes et al., 
2009; Papke et al., 2011). A second possibility is that the patch excision allows channels to access a 
refractory conformation that is distinct from the desensitized state and inaccessible to channels in intact 
membranes. In either case, it is clear that patch excision shifts the equilibrium among accessible states 
to heavily favor a long-lived, non-conductive conformation.  
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Because we consistently observed extreme rundown of α3β4 activity in outside-out patches, but not in 
the whole-cell configuration, we set out to determine whether changes in the receptor’s environment 
resulting from patch excision could underlie this irreversible loss of channel responsiveness. 
Determining the cause of this rundown is likely to further our understanding of the regulation of these 
receptors, and it might shed light into their role in diabetic neuropathy. 
3.3.2 Irreversible desensitization of α3β4 receptors in the outside-out configuration is not due to 
cysteine oxidation 
Recently, Campanucci et 
al. provided evidence 
that the irreversible 
depression of currents 
mediated by α3-
containing receptors in 
SCG neurons occurs as a 
result of oxidation of the 
–4’ cysteine in the M1-
M2 linker (Campanucci et 
al., 2010). The –4’ 
cysteine was specifically 
implicated, since 
Figure 3.2. The configuration dependent behavior of the α3β4 AChR. A, Whole-cell current trace 
recorded from a cell transfected with human α3 and β4 AChR-subunit and RIC-3 cDNAs. Currents were 
elicited by the application of a 0.5-Hz train of 200-ms pulses of 1-mM ACh. The trace shown is 
representative of the typical behavior of wild-type α3β4 AChRs in the whole-cell configuration. B, 
Outside-out current trace from a cell transfected with cDNA coding human α3 and β4 AChR subunits 
and RIC-3. Currents were elicited by the application of a 1-Hz train of 5-ms pulses of 1-mM ACh. The 
trace shown exemplifies the extreme peak response depression seen with the wild-type α3β4 AChRs in 
outside-out patches. Further applications of 1-mM ACh pulses to excised patches of membrane 
containing α3β4 AChRs elicited no response, even after prolonged, several-minute long incubations in 
the absence of ACh. C, A pair of 2-s pulses was applied to the same patch, allowing for a 5-min 
interpulse interval. Despite the long neurotransmitter-free interval between pulses, channel activity 
was never recovered. 
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mutation of this cysteine to an alanine completely prevented the irreversible rundown seen under 
oxidizing conditions. However, as shown in Figure 3.3, mutation of the α3 –4’ cysteine to alanine did not 
prevent the irreversible rundown from occurring in outside-out patches. This result implies that the 
irreversible depression seen in outside-out patches occurs through a mechanism other than oxidation of 
the wild-type cysteine at the –4’ position of the α3 subunit.  
 
 
In addition to testing the α3(C238A)β4 construct, we also investigated whether cotransfection with 
cDNA for the α5 subunit could prevent the irreversible depression of currents in excised patches, as it 
did for the wild-type α3β4 receptors (Papke et al., 2011). Results are tabulated in Table 3.1. As in the 
case of the wild-type α3β4α5 receptors, we observed that some patches with α5-containing AChRs did 
not exhibit the rundown characteristic of the α3β4s (with or without the cysteine-to-alanine mutations). 
However, as evidenced in Table 3.1, the α3(C238A) mutation alone never rescued channel function in 
outside-out patches. 
 
Figure 3.3. The configuration dependent 
behavior of α3(C238A)β4 AChRs. A, The 
α3(C238A) mutation does not affect the 
irreversible depression seen in outside-out 
patches of membrane. Despite the low 
frequency of the train of pulses (1-Hz), the peak 
responses completely depress. Furthermore, as 
is the case for the wild-type α3β4 AChRs, the 
responsiveness of the channels in the patch 
appears to be permanently compromised after a 
single experiment. B, Behavior of the 
α3(C238A)β4 AChRs in the whole-cell 
configuration. α3(C238A)β4 AChRs exhibit very 
little peak depression in response to a low 
frequency (0.5-Hz) train of 200-ms pulses. 
Furthermore, the depression of currents in 
response to pulse protocols is reversible, unlike 
the depression in A. The configuration-
dependent behavior exhibited by this construct 
is essentially the same as that seen in wild-type 
receptors. Note that the baseline in A appears to 
be noisier than that in B because the current 
scale in B is substantially larger. 
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Table 3.1. Kinetic parameters of α3β4 AChRs in outside-out patches 
 
Construct 
Fraction of 
patches 
exhibiting reliable 
responses 
Entry into 
desensitization 
(ms)
a
 
 
Deactivation (ms) 
a
 
α3 β4 0/10 315 ± 51 103 ± 38 
α3(C238A) β4 0/8 - 132 ± 21 
α3 β4 α5 3/15 - 
Unreliable kinetics 
11.4 ± 2.7 (0.472 ± 0.075) 
60.8 ± 8.4 (0.528 ± 0.075) 
Reliable kinetics 
6.0 ± 1.6 (0.619 ± 0.033) 
34.3 ± 8.6 (0.381 ± 0.033) 
α3(C238A) β4 α5 4/10 297 ± 56 53.1 ± 8.0 (0.521 ± 0.052) 
13.0 ± 3.0 (0.479 ± 0.052) 
a
 Time constants of deactivation and entry into desensitization were estimated for various combinations 
of α3, β4, and α5 subunits. For the α3(C238A)β4α5 combination, reliable (4/10) and unreliable (6/10) 
time constants were similar, and, hence, they were pooled for analysis. However, for the α3β4α5 
construct, time constants were significantly different depending on whether they were recorded from 
“reliable” patches (where reliable denotes the absence of the extreme, irreversible rundown observed 
in wild-type α3β4-containing patches). Thus, deactivation kinetics for reliable and unreliable patches are 
presented separately. All constructs were cotrasfected with cDNA encoding for RIC-3. 
 
3.3.3 Cysteine oxidation effect is not seen in the whole-cell configuration 
In an attempt to induce the oxidation-mediated rundown of α3β4 receptors (described in Campanucci et 
al., 2010), we added 100 µM H2O2 both intracellularly, via the patch-pipette, and extracellularly, through 
the solutions applied with the θ-tube, to cells being recorded from in the whole-cell configuration. 
However, despite the highly oxidizing conditions, no irreversible rundown was observed, implying that 
either the –4’ cysteines were not oxidized or that their oxidation had no effect on the response of the 
channel to the applied trains of ACh pulses (Figure 3.4, panels A and B). As a control, to verify our ability 
to oxidize cysteines, we engineered a ring of cysteines at the 6’ position of the human muscle AChR. 
Channels with the entire ring of cysteines had no functional expression, so we reduced the number of 
cysteines in the ring from five to two by cotransfecting cDNAs coding wild-type α1 and ε subunits with 
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Figure 3.4. Kinetics of wild-type α3β4 AChRs and AChR6’C in the presence and absence of H2O2. In all 
panels, red traces are responses of the wild-type α3β4 AChR in the absence of H2O2, and blue traces 
are responses of the wild-type α3β4 AChR in the presence of H2O2. A, Recovery from desensitization 
for the α3β4 AChRs is not affected by 100-µM H2O2 applied both from intracellular and extracellular 
sides of the membrane in the whole-cell configuration. This result is in contrast to the extreme 
depression predicted by the cysteine oxidation hypothesis; if cysteine oxidation caused irreversible 
depression, then the blue trace should appear to be a straight line with the fraction of receptors 
recovered identically equal to zero. B, Peak responses to low frequency trains of pulses were 
normalized and averaged across whole-cell recordings to generate plots showing the average peak 
response depression for each set of conditions. Of course, this procedure necessitates the first 
response always having amplitude equal to 1, represented by the black circle. Low frequency train 
responses are affected to a small degree by symmetrically applied 100-µM H2O2, but depression was 
reversible and, thus, not the same as that reported by Campanucci et al. C, Representative responses 
of the AChR6’C construct in outside-out patches in the presence (green) and absence (purple) of 10-
mM H2O2, applied via the patch-pipette. The wild-type muscle AChR response is shown in grey. We 
also ran the control of applying 10-mM H2O2 (via the patch-pipette) to the wild-type AChR; this 
treatment had no effect on the rate of entry into desensitization, implying that the speeding up of 
desensitization seen in C is due to cysteine oxidation. 
cDNAs coding mutant β1 and δ subunits (a construct hereafter referred to as the “AChR6’C”). Probing the 
AChR6’C in the outside-out configuration with 10-mM H2O2 applied to the intracellular side of the 
membrane, we observed a 6.1-fold decrease in the time constant of entry into desensitization relative 
to its value in the absence of H2O2 (Figure 3.4C). This result is consistent with previous cysteine 
accessibility studies, in which reactions involving cysteines engineered in the 6’ position affected the 
kinetic properties of serotonin and ACh receptors (Reeves et al., 2001; Akabas et al., 1994). Applying 10-
mM H2O2 to the wild-type muscle AChR did not significantly change the rate of entry into 
desensitization, implying that the oxidation of the engineered 6’ cysteines was responsible for the 
change in the time constant.  
Another set of mutations was engineered in the human muscle AChR to yield a full ring of cysteines at 
position –4’ (the “AChR–4’C” construct), to mimic the –4’ cysteine ring in the α3β4 AChR. Figure 3.5 shows 
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that, while the kinetics of recovery from desensitization were somewhat altered with respect to the 
wild-type muscle AChR, the AChR–4’C did not exhibit the irreversible depression of the α3β4 receptors. 
All of these results were unexpected, given the straightforward nature of the cysteine-oxidation 
hypothesis (Campanucci et al., 2010) and the seemingly direct nature of our experiments. The 
discrepancy between our results and those presented in Campanucci et al. begs the question of what 
could underlie the difference. One possibility is that the rat and human receptors behave differently, 
although it seems unlikely that they could be very different from each other given the high degree of 
sequence conservation between the relevant regions of these receptors. The solution to this conundrum 
will likely yield interesting insight into the function of these elusive receptors, particularly in regards to 
their role in diabetic neuropathy.  
 
3.3.4 Mutagenesis study of the –4’ position in α3β4 AChRs 
Because we could not induce the irreversible depression of α3β4 receptors via cysteine oxidation, we 
used site-directed mutagenesis to probe the influence of changes to the –4’ position on channel kinetics. 
We reasoned that, if oxidation converted the cysteine into another species (that is, to sulfenic, sulfinic, 
or sulfonic acid), then we might be able to reproduce the irreversible loss of responsiveness by mutating 
Figure 3.5. Kinetic properties of the human muscle AChR–4’C construct. The AChR–4’C is shown in blue, 
and the wild-type AChR is shown in green. All experiments are performed in outside-out patches. A, The 
AChR–4’C recovers slightly more slowly than the wild-type. If the addition of cysteines led to the 
irreversible rundown seen in α3β4 AChRs, the blue trace in A would appear to be a straight line with the 
fraction recovered equal to zero. B, The entry into desensitization timecourse of the AChR–4’C shows no 
apparent change relative to the human wild-type AChR. C, There is more peak response depression over 
the course of a train of pulses for the AChR–4’C construct, consistent with entry into desensitization being 
unaltered while recovery is slowed down. Again, although there is somewhat increased depression of 
the peak responses, the depression of peak responses does not go all the way to the baseline, and 
channels recover in between pulse train protocols. Thus, results here indicate that the AChR–4’C 
construct does not undergo the irreversible depression seen in wild-type α3β4 AChRs in outside-out 
patches. 
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the wild-type cysteine to another amino acid. As shown in Figure 3.6, mutating the cysteine at the–4’ 
position of the α3β4 AChRs to alanine, leucine, methionine, glutamine, or serine made little to no 
difference in the kinetics of deactivation, recovery from desensitization, or entry into desensitization, 
nor did it affect the responses of α3β4 AChRs to repetitive stimulation. We can think of two possibilities: 
either the oxidized sulfydryl is involved in very specific interactions that are not readily mimicked by the 
tested amino acid substitutions, or the oxidation leads to formation of a disulfide bridge (which clearly 
would not be well-mimicked by amino-acid substitution). However, on the latter possibility, in order for 
a disulfide bond to form, the α-carbons of the interacting residues cannot be separated by more than 
6.5 Å (Sowdhamini et al., 1989). Sequence comparison between GLIC and other members of the 
pentameric ligand gated ion channel (pLGIC) superfamily suggests that its M1-M2 loop tyrosines align 
Figure 3.6. Kinetics of α3β4 AChRs containing α3 mutations. All experiments are performed in the 
whole-cell configuration. A, Deactivation timecourses. Deactivation is consistently faster in mutant 
receptors than in wild-type receptors, but only by a small factor compared to the changes seen in, for 
example, well known mutations to the pore-lining residues of M2. B and C, Mutant constructs exhibit 
indistinguishably similar kinetics of recovery from desensitization and entry into desensitization 
compared to the wild-type receptor. D and E, Responses to low frequency trains of pulses show little 
difference between wild-type and mutant receptors. In both cases, the responses to each pulse were 
normalized to that of the first pulse, to enable averaging across patches. The black circle represents 
the first pulse, which was set through our normalization procedure to have a value of one. Error bars 
are standard errors. Overall, the results shown in A-E demonstrate that point mutations to the –4’ 
position tend to have very little effect on channel kinetics. This finding suggests that, in order for 
oxidation of the –4’ cysteine to a higher order oxidation species (sufinic, sulfonic, or sulfenic acid) to 
cause an irreversible rundown of channel function, it must lead to a very specific interaction between 
the species and its environment that is not readily mimicked by point mutations at the position. 
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with the –4’ position. In the GLIC structures (3EAM – Boquet et al., 2009; 3EHZ – Hilf and Dutler, 2009), 
the nearest neighboring α-carbons of the –4’ tyrosines are on average 11.3 Å apart, which is 
substantially farther than the minimum distance necessary for disulfide bridges to form. Note that we 
used the GLIC structure instead of the cryo-EM AChR structure (Unwin, 2005) because, in the latter, the 
primary sequence of M2 is likely to be misthreaded (Cymes and Grosman, 2008; Hibbs and Gouaux, 
2011). It still remains an open topic whether the GLIC structure represents an open, closed, or 
desensitized state (Gonzalez-Gutierrez and Grosman, 2010; Gonzalez-Gutierrez et al., 2012); however, 
the backbones of the GLIC and cryo-EM AChR structures, said to represent the open and closed states, 
respectively, place the α-carbons of the M2 segments in essentially the same position. Furthermore, the 
recent ELIC structure has them even further away from each other. Thus, there is no structural evidence 
that the α-carbons of the –4’ cysteines are any closer than 11.3 Å away from each other, suggesting that 
these residues are unlikely to be close enough to form disulfide bridges. 
3.3.5 Depletion of PIP2 does not promote rundown of α3β4 AChRs in the outside-out configuration 
PIP2 interactions are a common regulatory mechanism for many different types of ion channels (Suh and 
Hille, 2008; Gamper and Rohacs, 2012), including TRP channels (for example, TRPA1: Kim et el., 2008; 
TRPM7: Runnels et al., 2002; TRPM8: Liu and Qin, 2005; TRPV1: Prescott and Julius, 2003), P2X receptors 
(Bernier et al., 2008), KCNQ channels (Li et al., 2005; Suh et al., 2006), and many inward rectifying 
potassium channels (for example, Kir2.1: Lopes et al., 2002; Kurata et al., 2010b; Kir6.2: Kurata et al., 
2010a). The concentration of PIP2 in the membrane is controlled through a dynamic balance of 
phosphatase and kinase activity, as well as through spontaneous cleavage. In excised patches of 
membrane, kinase activity and ATP are lost, so that cleaved PIP2 cannot be recovered (Suh and Hille, 
2008).  
To directly investigate the possibility that PIP2 loss is 
Figure 3.7. diC8 PIP2 does not 
prevent the irreversible depression 
of α3β4 AChRs in outside-out 
patches. Series of long (2-s) pulses of 
1-mM ACh were delivered to outside-
out patches of membrane excised 
from cells transfected with α3 and β4 
AChR-subunit and RIC-3 cDNAs. 200-
µM diC8 PIP2 was included in the 
patch pipette. As shown, although the 
initial pulse elicited a sizeable peak 
response comprised of the openings 
of several tens of individual channels, 
further pulses elicited no measurable 
response from the membrane. 
 
 76 
 
responsible for the rundown of α3β4 AChRs in the outside-out configuration, we added 200-µM 
dioctanoyl (diC8) PIP2, a water soluble PIP2 that spontaneously self-inserts into cellular membranes, to 
the patch pipette. The inclusion of diC8 PIP2 in the patch pipette is intended to keep the level of PIP2 in 
the membrane high in outside-out patches. As shown in Figure 3.7, inclusion of the diC8 PIP2 in the 
patch pipette had no apparent effect on receptor rundown, implying that the rundown of α3β4 AChRs in 
excised patches is caused by a factor other than PIP2 depletion. This result suggests that PIP2 depletion is 
not the culprit for the irreversible loss of α3β4 AChR function in excised patches of membrane. 
 
3.3.6 Actin-channel interactions have no effect on receptor rundown 
Patch excision very likely disrupts the cortical actin cytoskeleton, and there are many known cases of 
channels interacting with actin, including epithelial Na+ channels (ENaCs; Berdiev et al., 1996), nuclear 
ion channels (Prat and Cantiello, 1996), P2X1 receptors (Lalo et al., 2011) and GlyRs (van Zundert et al., 
2002). In the case of the ENaCs, channels are known not to function properly in the absence of this 
actin-protein interaction (Prat et al., 1993). To investigate whether the loss of an actin-channel 
interaction is involved in the rundown of α3β4 AChRs, we incubated cells in PBS containing 10-µM 
latrunculin B (LatB), a membrane-permeable compound that prevents actin polymerization, for at least 
1 h prior to recording (35 min is sufficient; Hummel et al., 2010). Because LatB prevents actin 
Figure 3.8. Phalloidin and DapI stain 
of control and LatB-treated HEK 
cells. Cells were transfected with 
cDNA encoding the α3 and β4 
subunits, as well as RIC-3. Pictures 
were taken at a 63x magnification 
near the basal surface of the cells, to 
visualize stress fibers. In all images, 
the phalloidin stain is shown in red, 
and the DapI stain (highlighting the 
nuclei) is shown in blue. A, Stains of 
cells left untreated with LatB. In 
both images, stress fibers are clearly 
visible (some salient examples of 
these fibers are indicated with white 
arrows), reflecting normal 
cytoskeletal structure. B, Stains of 
cells treated with 10-µM LatB for 
one hour. In both cases, no stress 
fibers are visible, indicating 
successful disruption of the actin 
cytoskeleton. 
 
 77 
 
polymerization, and since F-actin is maintained through a dynamic balance of polymerization and 
depolymerization, LatB indirectly causes the depolymerization of actin filaments throughout the cell. In 
Figure 3.8, we show through phalloidin staining that our LatB treatment successfully disrupted the actin 
cytoskeleton, as desired. However, this treatment did not lead to irreversible depression in the whole-
cell configuration (Figure 3.9). Since eliminating F-actin-protein interactions does not induce irreversible 
depression of α3β4 AChR-mediated currents in the whole-cell configuration, we conclude that 
disruption of the actin cytoskeleton cannot account for the rundown observed in outside-out patches. 
 
3.3.7 Rundown in the whole-cell configuration is not correlated with receptor density 
Only a small minority of cells assayed in the whole-cell configuration did not exhibit ACh-evoked 
currents in response to 1-mM applications. However, the majority of outside-out patches exhibited no 
currents upon application of 1-mM ACh. A plausible explanation for this discrepancy is that, since 
outside-out patches have much less surface area than the entire cell membrane (see, for example, 
Sokabe and Sachs, 1990; Sakmann and Neher, 1995), the average receptor density in the membrane is 
sufficiently large to produce currents when the entire cell membrane is being assayed but is 
Figure 3.9. Recovery of α3β4 AChRs after incubation with 10 µM LatB. Multiple 5-s ACh pulses were 
applied in the whole-cell configuration to α3β4 AChRs that had been in the continuous presence of 10-
µM LatB for 1 h prior to recording. To prevent actin polymerization from occurring during the recording, 
10-µM LatB was also added to the patch pipette. The two sets of hash marks denote the omission of 
the long interpulse interval from the trace, which was left out to highlight the first and second 
applications of 1-mM ACh. Clearly, receptors completely desensitize during the first pulse, and they 
completely recover during the interpulse interval. Hence, LatB treatment does cause irreversible 
depression of α3β4 AChRs responses in the whole-cell configuration. 
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insufficiently large for producing currents in an 
excised patch (which is only a small fraction of 
the surface area of the cell membrane). Hence, 
the average cell giving rise to outside-out data is 
likely to have an unusually high density of α3β4 AChRs, compared to that of the average cell giving rise 
to a whole-cell recording. It follows that the irreversible depression could be a property of the α3β4 
channels that emerges when the receptor density in the membrane is abnormally high. Indeed, receptor 
density has been shown to affect the kinetics of entry into desensitization of homomeric α1 GlyRs 
(Legendre et al., 2002), and hence, there is a precedent for such an effect. 
To determine whether there is a relationship between receptor density and the configuration-
dependent rundown, we compared receptor density (as reflected by the initial peak amplitude 
normalized to the whole-cell capacitance) to the extent of rundown observed in whole-cell recordings. 
The extent of rundown was defined as the peak amplitude 10 min after the first pulse was applied, 
normalized to the initial peak amplitude. As shown in Figure 3.10, there does not seem to be any 
dependence of receptor rundown on receptor density. Thus, we conclude that the unusually high 
receptor density necessary to achieve outside-out recordings has no role in the rundown observed in 
outside-out patches. 
3.4 Concluding remarks 
In the end, we are still left with unanswered questions regarding the behavior of α3β4 AChRs in outside-
out patches, and regarding the differences between our results and those of Campanucci et al. 
(Campanucci et al., 2010). It is likely that getting to the bottom of these differences will lead to 
Figure 3.10. The extent of rundown in the whole-
cell configuration does not depend on receptor 
density. 5-s pulses of 1-mM ACh were applied 
once every 2 min for 10 min. The response to the 
initial pulse was normalized to the whole-cell 
capacitance to get a quantity that is proportional 
to receptor density; this quantity is the 
independent variable in the plot. The extent of 
rundown was determined by normalizing the 
current at the final pulse (delivered 10 min after 
the initial pulse) to the initial peak current 
amplitude; the extent of rundown is the 
dependent variable in the plot. Each data point 
was obtained from a different whole-cell 
recording. The straight line is a linear fit to the 
data, from which the corresponding R2 value was 
determined to be 0.0049. These data suggest that 
the receptor density is a poor predictor of the 
extent of rundown over the duration of the 
recording.  
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interesting insights into the biophysical properties of these receptors and will have implications for the 
role of these receptors in diabetic neuropathy. In addition to uncovering the interesting discrepancy 
regarding the cysteine oxidation hypothesis, we have also demonstrated that actin-receptor 
interactions, PIP2 depletion, cysteine oxidation and receptor-density-dependent effects are unlikely to 
underlie the depression seen in outside-out patches.  
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Chapter IV – The role of the M1-M2 linker of pLGICs in gating and desensitization 
The intracellular M1-M2 linker of pentameric ligand-gated ion channels (pLGICs) connects the pore-
lining M2 α-helix with the adjacent M1 α-helix. Despite its proximity to the narrowest constriction of the 
open pore, the M1-M2 linker’s role in gating and desensitization of pLGICs has yet to receive thorough 
investigation. To this end, we engineered a series of mutations to the adult muscle acetylcholine 
receptor (AChR) and the α1 glycine receptor (GlyR). In the muscle AChR, alanine, glycine, proline, and 
valine scans were performed on the M1-M2 linker of the α1 subunit, and in the GlyR, alanine and 
threonine scans were performed on the M1-M2 linker; in both cases, the kinetic behavior of mutant 
constructs was measured in fast-perfused outside-out patches. Unlike mutations to M2 or the M2-M3 
linker, mutations to the M1-M2 linker have little to no effect on deactivation. We conclude that the M1-
M2 linker is unlikely to undergo large-scale movement during gating transitions. In both the GlyR and 
the AChR, large patch-to-patch variability complicated attempts to compare the kinetics of 
desensitization across wild-type and mutant receptors. Our data suggest that the variation in GlyR 
desensitization timecourses is an accurate reflection of patch-to-patch variation in receptor kinetics, and 
not an artifact related to the large ensemble currents seen in excised patches (as has been previously 
proposed). To investigate this variability, we turned to the M3-M4 loop, which has previously been 
shown to modulate desensitization kinetics through post-translational modification. To our surprise, we 
found that replacing the M3-M4 loop of the α1 GlyR with the M3-M4 heptapeptide of the Gloeobacter 
violaceus pentameric ligand-gated ion channel (GLIC) had no apparent effect on the variability of 
desensitization, implying that the variability in desensitization kinetics is not due to intracellular 
modulation of the M3-M4 loop.  
4.1 Introduction 
The motion of the transmembrane M2 segment during gating and desensitization is one of the 
outstanding open topics in the field of pLGICs. Despite the recent wealth of X-ray crystallographic 
structures (Hilf and Dutzler, 2008; Bocquet et al., 2009; Hilf and Dutzler, 2009; Hibbs and Gouaux, 2011), 
in addition to older cryo-EM data (Unwin, 2005) and functional substituted cysteine accessibility studies 
(Akabas et al., 1992; Karlin and Akabas, 1998), we are still lacking a clear mechanistic picture of the 
movements of the M2 helix during these fundamental processes. Even the location of the gate of the 
channel is contentious, with some groups finding it to be near the narrowest intracellular constriction of 
the pore (around –2’: Akabas et al., 1994; Wilson and Karlin, 1998), and others suggesting that it is 
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located at the center of the transmembrane region (around 13’: Panicker et al., 2002; Beckstein and 
Sansom, 2006; or 16’: Bocquet et al., 2009; Hilf and Dutzler, 2009).  
Although virtually nothing is known about the motion of the M2 segment during desensitization, site-
directed mutagenesis has provided some compelling data regarding its gating movements. Phi-value 
analysis has demonstrated that the conformational change of the M2 helix in the AChR does not take 
place all at once, but instead is propagated as a “conformational wave” from the extracellular domain to 
the intracellular end of M2 (Grosman et al., 2000b). There is also evidence that the gating motions are 
not very large; scans of the M1, M2, and M3 helices with basic residues have shown the open state of 
the AChR to be similar to the closed cryo-EM structure, implying that gating motions of the pore-lining 
helices are likely to be small (Cymes et al., 2005; Cymes and Grosman, 2008).   
Given that M2 is an α-helix flanked by two linkers, it seems likely that motions associated with gating 
and desensitization involve tilting of the α-helix, although there is no concrete information about the 
location of the hinge about which tilting occurs. The tilting hypothesis has existed for some time (Lynch 
et al., 1997), and is still prevalent in recent studies on this subject (Zhu and Hummer, 2010). One 
approach to investigating this hypothesis is to make mutations to the linkers flanking M2. If M2 is indeed 
tilting, then the linkers are likely to be involved in force transduction from intra- and extracellular 
domains to M2. Indeed, the M2-M3 linker has been proposed to perform exactly this function during 
gating, transducing signals from the binding domain to the pore (Lee et al., 2008; Lee et al., 2009).  
Of the two linkers flanking M2, the M2-M3 linker has gotten more attention, likely due to structural data 
that shows its direct interaction with the extracellular domain. Extensive mutagenesis work performed 
on this loop has uncovered many mutations that dramatically affect channel gating (Grosman et al., 
2000a; Lee et al., 2009). Comparatively little is known about the effects of altering the M1-M2 linker. 
Recently, it has been suggested that oxidation of a cysteine at the –4’ position causes channels to enter 
a long-lived desensitized state (Campanucci et al., 2008). Also, a naturally occurring mutation to the –2’ 
position of the GlyR M1-M2 linker (P250T) has been shown to lead to hyperekplexia and to alter the 
desensitization kinetics of human glycine receptors, although it is unclear whether the effect on 
desensitization alone accounts for the disease phenotype (Saul et al., 1999; Breitinger and Becker, 
2002). Furthermore, an alanine scan of the M1-M2 linker was performed in the α1 GlyR, and, in W243A 
and I244A constructs, the rate of entry into desensitization was dramatically affected, as measured in 
the whole-cell configuration (Lynch et al., 1997).  
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Based on this mutagenesis work, the M1-M2 linker (along with the M2-M3 linker) was proposed to 
change conformations in order to accommodate the gating motion of M2 (Lynch et al., 1997; Breitinger 
et al., 2001). However, more recently, based upon the structures of Erwinia chrysanthemi ligand-gated 
ion channel (ELIC) and GLIC bacterial channels, it has been proposed that movement of M2 during gating 
is mostly mediated by conformational changes of the M2-M3 linker, and that the M1-M2 linker does not 
undergo much of a conformational change (Zhu and Hummer, 2010). The latter work is predicated on 
the assumption that the GLIC (Boquet et al., 2009; Hilf and Dutzler, 2009) and ELIC (Hilf and Dutzler, 
2008) structures represent the open and closed states, respectively, of all members of the superfamily, a 
notion that has been recently called into question (Gonzalez-Gutierrez and Grosman, 2010; Gonzalez-
Gutierrez et al., 2012).  
Clearly, the issue of whether M1-M2 is involved in the conformational changes associated with gating 
and desensitization merits further investigation. It is worth noting that, conceivably, the opening-closing 
transition gate could be distinct from the desensitization gate, as is the case for at least some K+ 
channels (Cuello et al., 2010; Cuello et al., 2010). In an effort to gain insight into the mechanism of 
gating and desensitization transitions, we performed a thorough scanning mutagenesis on the M1-M2 
linkers of the muscle AChR and GlyRs, as well as isolated mutations to the AChR M2 helix and M2-M3 
linker to gain a basis of comparison for functional effects of the M1-M2 mutations. Mutations to the 
AChR M1-M2 linker had inconsistent and generally mild effects on channel gating, compared to the large 
effects that mutations to M2-M3 or M2 have. The inherent variability in the kinetics of entry into 
desensitization complicated our efforts to quantify the effects of M1-M2 mutations on channel 
desensitization, in both the AChR and the GlyR.  
Timecourses of desensitization have been shown to be highly variable for the AChR (Franke et al., 1993) 
and the GlyR (Papke et al., 2011). It has also been demonstrated that mutations to the M3-M4 loop can 
affect desensitization kinetics (Milone et al., 1998), and that the phosphorylation state of different 
residues in the M3-M4 loop of the AChR β1 and δ subunits can also affect desensitization kinetics 
(Huganir et al., 1986; Hopfield et al., 1988; Paradiso and Brehm, 1998). Hence, one plausible explanation 
for the cell-to-cell variability in desensitization kinetics is that the set of post-translational modifications 
undergone by the M3-M4 loop varies from cell to cell. To eliminate this possibility, we replaced the long 
M3-M4 loop of the human α1 GlyR with the M3-M4 heptapeptide of the bacterial homolog GLIC. 
Surprisingly, this construct still exhibits the extreme variability in desensitization characteristic of the 
wild-type GlyR, despite the apparent lack of intracellular sites for post-translational modification. Thus, 
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we infer that the variability in GlyR behavior is not the result of variability in the state of post-
translational modification of the M3-M4 loop. More generally, since modifications to the intracellular 
linkers have small-to-negligible effects on channel kinetics, we conclude that these linkers are unlikely to 
be integrally involved in the conformational changes associated with gating and desensitization. 
4.2 Methods 
The methods used in this section are the same as those used in Chapters II and III. In the interest of 
avoiding repetition, we will not reproduce them here, but instead refer the reader back to the preceding 
two Chapters for any methodological questions that might arise. 
4.3 Results and discussion 
4.3.1 Mutations to the human muscle AChR M1-M2 linker have little effect on deactivation 
In order to quantitatively assay the kinetic effects of mutations to the M1-M2 linker, we performed site-
directed scanning mutagenesis on the adult human muscle AChR. Alanine, glycine, proline, and valine 
scans were performed on the M1-M2 linker of the α1 subunit, between residues P236 (–6’) and G240 (–
2’). Representative traces for the deactivation timecourses of each of the mutants are presented in 
Figure 4.1, and the corresponding time constants are presented in Table 4.1.  The rate of deactivation 
was unchanged in four constructs (T237V; D238A, D238P, S239G), sped-up in five constructs (T237A: 
1.8-fold increase; T237G: 3.4-fold increase; D238G: 1.2-fold increase; D238V: 1.4-fold increase; G240A: 
1.4-fold increase) and slowed down in two constructs (T237P – 2.1-fold decrease, S239A – 1.6-fold 
decrease). In addition to the scans, we also engineered a construct missing the A238 residue in the 
linker, and another construct with an extra alanine inserted between A238 and S239 (constructs 
referred to as “A238del” and “A239ins”, respectively; Table 4.2). A239ins exhibited no apparent difference 
in deactivation kinetics compared to the wild-type AChR, while the deletion of A238 caused the rate of 
deactivation to slightly quicken. 
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Table 4.1. Kinetic measurements of α1 AChR mutant constructs. 
AChR  α1 
mutation
 a
 
τdesensitization (ms) 
(2-component) 
τdesensitization 
(ms) (1-
comp.) 
1-comp. 
preva-
lence 
τdeact. 
(ms) 
τrecovery 
wild-type 
(August 
2010) 
287 ± 115 (0.448 ± 0.067) 
38.0 ± 6.2 (0.552 ± 0.067) 
28.3 ± 9.0 5/16 
2.52 ± 
0.24 
3.4 ± 1.6 s (0.215 ± 0.083) 
414 ± 63 ms (0.785 ± 0.079) 
T237A 
124 ± 41 (0.412 ± 0.138) 
24.8 ± 7.5 (0.588 ± 0.138) 
26.3 ±  6.9 7/12 
1.38 ± 
0.24 
5.7 ± 0.8 s (0.244 ± 0.031) 
549 ± 37 ms (0.756 ± 0.030) 
D238A 
374 ± 160 (0.244 ± 0.070) 
48.3 ± 5.0 (0.756 ± 0.070) 
12.2 ± 2.8 8/10 
3.20 ± 
0.62 
6.6 ± 2.4 s (0.218 ± 0.076) 
763 ± 105 ms (0.782 ± 
0.074) 
S239A - 13.2 ± 2.8 10/10 
4.13 ± 
0.48 
8.3 ±3.6 s (0.154 ± 0.060) 
930 ± 93 ms (0.846 ± 0.059) 
G240A 
18.5 ± 4.7 (0.473 ± 0.009) 
3.6 ± 2.3 (0.527 ± 0.009) 
8.99 ± 4.29 6/8 
1.83 ± 
0.19 
5.2 ± 2.0 s (0.228 ± 0.074) 
436 ± 76 ms (0.772 ± 0.070) 
T237G - 10.9 ± 1.4 5/5 
0.75 ± 
0.06 
4.54 ± 1.38 s (0.218 ±0.055) 
398 ± 51 ms (0.782 ± 0.052) 
D238G - 17.3 ± 3.6 5/5 
2.05 ± 
0.13 
9.52 ± 3.78 s (0.151 ± 0.040) 
445 ± 47 ms (0.849 ±0.039) 
S239G - 25.8 ± 3.7 3/3 
2.23 ± 
0.57 
900 ± 56 ms 
T237P 
31.1 ± 4.1 (0.478 ± 0.060) 
12.0 ± 0.6 (0.522 ± 0.060) 
15.2 ± 0.7 2/4 
5.19 ± 
0.17 
2.54 ± 0.17 s 
D238P - 23.1 ± 3.6 5/5 
2.94 ± 
0.49 
1.00 ± 0.16 s (0.788 ± 0.094) 
7.65 ± 3.46 s (0.212 ± 0.097) 
T237V - 13.4 ± 3.6 5/5 
2.34 ± 
0.26 
1.03 ± 0.50 s (0.492 ± 0.277) 
4.21 ± 1.62 s (0.508 ± 0.281) 
D238V - 11.7 ± 1.1 5/5 
1.74 ± 
0.32 
4.79 ±2.28 s (0.226 ± 0.096) 
598 ± 107 ms (0.774 ±0.092) 
a
 Mutant constructs tested in between August 2010 and June2011 wild-type AChR data (Table 4.3) 
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To gain a basis of comparison for the size of the effects of human muscle AChR M1-M2 linker mutations, 
we also engineered M2 segment and M2-M3 linker mutations that are known to profoundly impact 
deactivation (Table 4.2). In general, mutations to the pore-lining M2 segment have a remarkably 
consistent effect on deactivation kinetics (Chen and Auerbach, 1998; Mitra et al., 2005), supporting the 
widely-accepted notion that the M2 helix is integrally involved in the conformational change associated 
with gating [indeed, the dynamics of this large-scale conformational change have been studied in great 
detail (Grosman et al., 2000b)]. Mutations to the M2-M3 linker are known to have somewhat varied 
effects on gating, although the majority of described mutations lead to a loss of function (Grosman et 
al., 2000a; Jua et al., 2007). A large fraction of previously described mutations to the M2-M3 linker lead 
Figure 4.1. The effect of M1-M2 linker mutations on deactivation. A, Alanine, B, glycine, C, proline and 
D, valine scans were performed on the M1-M2 linker of the AChR α1 subunit. All displayed traces were 
chosen because they were most representative of the average behavior of each construct. All traces 
were normalized so that their peak amplitudes coincided, for purposes of visual comparison. In every 
panel, the red trace represents average wild-type behavior; this behavior remained unchanged across 
all gathered wild-type data (see Table 4.3). Many constructs exhibited no significant difference in their 
deactivation timecourse relative to that of the wild-type. In some other cases, deactivation 
timecourses were sped up, and in yet others, they were slowed down. However, in all cases, any 
deviations from wild-type behavior were small compared to the effects of well-known mutations to the 
M2 segment or the M2-M3 linker. 
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to aberrant gating, which is consistent with the idea that very specific interactions between the M2-M3 
linker and the β1-β2 loop of the extracellular domain are necessary for wild-type-like channel gating 
(Lee et al., 2008; Lee et al., 2009). 
                       Table 4.2. Kinetic parameters of other α1 AChR mutant constructs. 
AChR  α1 
mutation
 a
 
τentry into desensitization (ms)
 b
 τdeactivation (ms) 
wild-type 
(May/June2012) 
20.90 ± 4.41 2.41 ± 0.21 
L251A 402 ± 140 
273 ± 24 (0.578 ± 0.172) 
36.9 ± 28.7 (0.422 ± 0.172) 
S268I 15.54 ± 1.31 1.75 ± 0.11 
S269I 47.28 ± 13.12 19.7 ± 3.0 
A238del 52.50 ± 14.93 1.52 ± 0.11 
A239ins 14.28 ± 4.46 2.30 ± 1.20 
a
 Mutant constructs presented here were tested during the same time period that the May/June 2012 
data was gathered for the wild-type AChR (see Table 4.3). 
b
 All mutant constructs here consistently had desensitization timecourses that were well-fit with a single 
exponential component 
Comparison of our M1-M2 linker mutagenesis data 
with M2 and M2-M3 mutagenesis data suggests that, 
when the rate of deactivation was affected by M1-M2 
linker mutations, the magnitude of the effect was 
invariably small compared to the effect of M2 segment 
or M2-M3 linker mutations. For example, L251A and 
Figure 4.2. Comparison of the kinetics of M1-M2 linker mutants with kinetics of a M2 segment 
mutant. Deactivation timecourses of M2 segment and M1-M2 linker mutant constructs are compared, 
with each timecourse normalized so that the peak amplitudes of the traces coincide. All traces were 
chosen to be representative of the average behavior of each construct. The α1 T237G mutation caused 
the most pronounced effect on deactivation out of all tested M1-M2 linker mutations. However, its 
effect on deactivation is small when compared to that of the well known leucine to alanine mutation at 
position 9’ (α1 L251A). Note that the α1 L251A trace appears to be noisier than the other two traces 
since its peak amplitude was much smaller (i.e. the signal to noise ratio was smaller); because this 
construct expressed very poorly, it was not possible to obtain traces with large peak amplitudes. We 
conclude that, when the M1-M2 mutations altered the deactivation timecourse, changes were small 
compared to the changes exhibited by M2 segment or M2-M3 linker mutant constructs. 
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S269I both exhibit changes in their rate of deactivation of an order of magnitude or more, while the 
most extreme change in deactivation timecourse of an M1-M2 mutant was by a factor of 3.4 (see Figure 
4.2 for a graphical comparison). Ultimately, considering the number of M1-M2 mutant constructs that 
we assayed, our results imply that the M1-M2 linker is unlikely to undergo a major structural 
rearrangement or significant change in microenvironment during channel gating in contrast to the M2 
segment and the M2-M3 linker. 
4.3.2 On the variability in the rate of entry into desensitization of the AChR 
The scanning mutagenesis experiments were performed on the M1-M2 linker of the AChR between 
August 2010 and June 2011. Human muscle wild-type data was gathered prior to the examination of the 
mutant constructs to gain a basis of comparison. Human wild-type desensitization timecourses generally 
fell into two categories: those well-fit (as determined visually) with one exponential component and 
those well-fit with two. In the initial data run, the majority of timecourses were well-fit with two 
components, while a minor fraction of them were well-fit with one (Table 4.3). As evidenced by the ratio 
of half-times of decay in the Table, patches well-fit with a single exponential component consistently 
had faster decay kinetics than those well-fit with two components.  
Table 4.3. Kinetic parameters of the human muscle AChR from different experimental time periods. 
Acqui-
sition 
period 
τentry into desensitization (ms) 
(2-comp.) 
τentry into 
desensitization (ms) 
(1-comp.) 
T1/2 of 
desensitization 
(ms)  
(2-comp/1-comp) 
Prevalence of 
1-comp. 
behavior 
τdeactivation 
(ms) 
August 
2010 
287 ± 115 (0.448 ± 0.067) 
38.0 ± 6.2 (0.552 ± 0.067) 
28.3 ± 9.0 54.9/19.6 5/16 2.52  ± 0.24 
June 2011 
272 ± 45 (0.310 ± 0.044) 
45.3 ± 9.17 (0.690 ± 0.044) 
- 47.8/- 0/5 2.83 ± 0.15 
May/June 
2012 
- 20.90 ± 4.41 -/14.5 12/12 2.41 ± 0.21 
August 
2012
 a
 
141 ± 77 (0.493 ± 0.076) 
26.2 ± 10.9 (0.507 ± 0.076) 
18.9 ± 6.27 37.3/13.1 4/10 2.81 ± 0.14 
Pooled 
data 
243 ± 64 (0.429 ± 0.043) 
36.4 ± 5.2 (0.571 ± 0.043) 
22.3 ±  3.4 48.9/15.4 21/43 2.70 ± 0.08 
a
 A new cell passage was prepared from frozen cells between the June 2012 and August 2012 
experiments 
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Table 4.1 shows that mutations to the M1-M2 linker usually eliminated the timecourses well-fit with two 
exponential components. Of the constructs that yielded timecourses best fit with two-component 
exponential functions, two of them (G240A and T237P) were clearly faster than the wild-type, while the 
other two (T237A and D238A) were wild-type-like. For most mutant constructs, single-component 
timecourses of decay were similar to the single-component behavior of the wild-type receptor (Table 
4.3). These results altogether imply that, for the most part, mutations to the M1-M2 linker eliminated 
the slowly-decaying wild-type behavior. Thus, the timecourses of mutant constructs were consistently 
faster than the “average” wild-type timecourses, or, in other words, they were consistently similar to 
the single-component wild-type behavior. 
 Because of this consistent difference between mutant and wild-type constructs, we became concerned 
about the possibility that the 
original wild-type data was 
anomalously slow. To make 
sure that values were internally 
consistent, we repeated wild-
type measurements in June 
2011, after having completed 
the scanning mutagenesis work. 
Reassuringly, analysis of the 
newer data yielded similar 
values for the rate of entry into 
desensitization, with all 
timecourses best fit with two 
component exponential 
Figure 4.3. The effect of scans of the M1-M2 linker on entry into desensitization in the human muscle 
AChR. A, Alanine, B, glycine, C, proline and D, valine scans were performed on the M1-M2 linker of the 
AChR α1 subunit. For this Figure, traces that are representative of the average construct behavior were 
chosen. In all panels, wild-type data gathered during the scanning mutagenesis data acquisition period 
(August 2010 – June 2011) is presented in red, and data collected a year later (May/June 2012) is 
presented in black (Table 4.3). Due to the instability of the desensitization timecourse over long periods 
of time, we conclude that it is necessary to gather wild-type and mutant data together on the same day 
of experimentation in order to be able to make a comparison between the timecourses. We also 
conclude that the rate of entry into desensitization is largely unaffected by mutations to the M1-M2 
linker. 
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functions. Results from both data runs are presented separately in Table 4.3. Because we had 
“bookended” our mutant construct measurements with wild-type measurements that were very similar, 
we concluded that the comparison of values between scanning mutagenesis constructs and the wild-
type receptor are valid, and that the rate of entry into desensitization was relatively stable during the 
period of experimentation. This set of data, taken on its own, suggests that the rate of entry into 
desensitization is consistently affected by mutations to the M1-M2 linker (Figure 4.3). We also found 
that the rate of recovery from desensitization is largely unaffected (Figure 4.4), and, as a control, we 
found that the responses of receptors to high-frequency stimulation were consistent with the rest of the 
kinetic data that we acquired (Figure 4.5). Hence, desensitization was the only kinetic parameter to be 
regularly affected by mutations to the M1-M2 linker. However, even considering this data set in which 
desensitization seems to be consistently affected, the effects of M1-M2 linker mutations are small 
compared to the effect of the M2 segment L251A mutation on desensitization (Table 4.2); in this latter 
mutant construct, desensitization is slowed down by over an order of magnitude. Thus, although 
desensitization appeared to be regularly affected by M1-M2 linker mutations, the effect was much less 
pronounced than the effect of the α1 
L251A mutation. 
Further experiments called into 
question whether mutations to the M1-
M2 linker even had an effect on 
desensitization. Upon our return to 
experimental work in 2012 (to gather 
the data presented in Table 4.2), we 
discovered, to our surprise, that the 
rate of entry into desensitization for the 
wild-type AChR exhibited behavior 
Figure 4.4. The effect of scans of the M1-M2 linker on recovery from desensitization in the human 
muscle AChR. A, Alanine, B, glycine, C, proline and D, valine scans were performed on the M1-M2 linker 
of the AChR α1 subunit. Axes labels are the same for all four panels. A 1-s conditioning pulse and a 
subsequent 100-ms test pulse were applied to outside-out patches of membrane. In the plot, the x-axis 
corresponds to the interval between these pulses, and the y-axis represents the fraction of receptors 
desensitized by the first pulse that recovered by the second one. Data points are average values across 
patches, and the error bars represent standard errors. For all mutant constructs that expressed, 
recovery from desensitization was wild-type-like. We conclude that recovery from desensitization is 
unaffected by mutations to the M1-M2 linker, implying that this region is unlikely to undergo a major 
change in conformation during this kinetic process. 
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similar to the mutants in Table 4.1. The timecourses from this more recent data set were entirely best fit 
with one-component exponential curves, with an average time constant of 20.90 ± 4.41 ms (Table 4.3), 
as opposed to earlier data, which typically required two exponential components, both of which were 
slower than 20.90 ms. When we obtained the newer wild-type data, we measured the time constant of 
the α1 T237G mutant to be 7.76 ± 1.93 ms, which is not significantly different from the older 
measurement presented in Table 4.1. We also measured the desensitization time constant of the α1 
D238G mutant to be 18.95 ± 3.48 ms, which is again not statistically different from what we originally 
found. Thus, although the timecourses of entry into desensitization for mutant constructs did not 
change significantly compared to what we had originally found, the wild-type timecourses sped up by a 
factor of 3.3 (comparing half-times of decay), and were now best fit with one component.  
This result has two evident, somewhat troubling implications: (1) some factor must have changed during 
the break between the first 
set of experiments and the 
second set, and (2) the 
number of exponential 
components necessary to 
achieve a good fit varies 
over long periods of time. 
In regards to the first point, 
we found that preparing an 
entirely fresh set of 
solutions had no effect on 
the rate of entry into 
desensitization, nor did 
altering the pressure 
Figure 4.5. The effect of scans of the M1-M2 linker on train responses in the human muscle AChR. A, 
Alanine, B, glycine, C, proline and D, valine scans were performed on the M1-M2 linker of the AChR α1 
subunit. Axes labels are the same for all four panels. Color coding is the same as in Figures 4.1, 4.3 and 
4.4. Traces shown are averages across many patches, and the error bars represent standard errors. 
Pulse train responses are a complex combination of the timecourses of deactivation, entry into 
desensitization, and recovery from desensitization. Here, all train responses show the expected 
amounts of depression based on the kinetics shown in Figures 4.1, 4.3 and 4.4. Hence, the kinetic data 
presented in Table 4.1 and Figures 4.1, 4.3, and 4.4 are internally consistent. 
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driving the solutions out of the θ-tube, nor did it make a difference having a lab member not otherwise 
involved with this project perform the experiments. We next examined the possibility that the 
difference in behavior was caused by starting a new cell passage from our frozen stock HEK-293 cells 
during the time between experiments. To examine whether the changing of the cell passage could be 
the culprit, we prepared yet another new cell passage, and, upon assaying these cells, we found the rate 
of entry into desensitization to be similar to that measured in the earlier data set (Table 4.3). This result 
suggests that some difference between the cells may have been the culprit, although we do not 
understand what the difference is on a mechanistic level.  
The fact that the rates measured for the wild-type AChR were internally consistent throughout the initial 
scanning mutagenesis experiments suggests that the data presented in Table 4.1 are consistent with the 
August 2010 data contained in that Table (i.e. mutations eliminated the slow, two-component type 
timecourses of entry into desensitization). However, due to the instability in the absolute rate of entry 
into desensitization, we cannot rule out the possibility that, on the days when we were acquiring the 
wild-type data, the receptors were behaving in a fundamentally different way compared to their 
behavior on the days when we tested the mutant constructs. We emphasize that, even if the original 
data were entirely self-consistent, our results would imply that desensitization is not affected much 
relative to the effect seen in M2 segment mutants. These newer results showing the variability in 
desensitization timecourses reinforce the notion that the 
effects of M1-M2 linker mutations on desensitization are 
small.  
Our results imply that, in future work examining the rate of 
entry into desensitization, whenever mutant constructs are 
being tested, wild-type control data should also be gathered 
on the same day. While such an approach is somewhat 
Figure 4.6. Patch-to-patch variability in the kinetics of deactivation and entry into desensitization. 
Deactivation time constants are plotted against desensitization half-times obtained from the same 
patches of membrane. Because desensitization is a component of the deactivation timecourse (Elenes 
et al., 2006), the deactivation time constant is expected to increase as the desensitization time constant 
increases. The black line is a linear fit of the data points, which has a y-intercept of 1.96 and a slope of 
0.026. If the variation were similar for deactivation and desensitization and the same trend held, then 
the slope of the fit would be close to 1. For visual comparison, the blue dashed line in the Figure has a 
slope equal to 1. Since the slope of the fit is 0.026, we conclude that the range of variation for 
deactivation is much smaller than the range of variation for desensitization.  
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cumbersome, it would lend more confidence to differences observed between rates. More generally, 
our results imply that the rate of entry into desensitization is much less stable than, for example, the 
rate of deactivation, as evidenced in Figure 4.6.  
 
TABLE 4.4. Kinetic measurements of GlyR α1 M1-M2 linker mutants 
Construct τdeactivation (ms) τentry into desensitization (ms) τrecovery (s) 
wild-type 
1316 ± 400. (0.292 ± 0.036) 
77.5 ± 17.6 (0.219 ± 0.051) 
3.76 ± 1.37 (0.488 ± 0.074) 
23.1 ± 4.8 (0.330 ± 0.061) 
3.97 ± 0.77 (0.670 ± 0.061) 
6.29 ± 0.93 (0.599 ± 0.072) 
0.489 ± 0.157 (0.401 ± 
0.068) 
N245A 
609 ± 165 (0.310 ± 0.090) 
45.3 ± 13.1 (0.337 ± 0.133) 
4.92 ± 2.73 (0.353 ± 0.098) 
21.8 ± 4.6 (0.525 ± 0.066) 
4.17 ± 1.16 (0.475 ± 0.066) 
15.33 ± 1.15 s (0.138 ± 
0.080) 
1.956 ± 0.210 (0.862 ± 
0.077) 
M246A 
962 ± 299 (0.416 ± 0.082) 
54.2 ± 14.9 (0.336 ± 0.084) 
4.98 ± 1.21 (0.248 ± 0.042) 
15.2 ± 0.8 (0.299 ± 0.023) 
4.96 ± 0.17 (0.701 ± 0.023) 
6.41 ± 2.40 
D247A 
703 ± 218 (0.277 ± 0.177) 
67.0 ± 2.7 (0.490 ± 0.247) 
6.01 ± 0.15 (0.233 ± 0.069) 
12.1 ± 1.6 (0.386 ± 0.037) 
3.35 ± 0.49 (0.614 ± 0.037) 
2.58 ± 0.30 
P250A
a
 
6010 ± 1434 (0.753 ± 
0.035) 
59 ± 21 (0.247 ± 0.035) 
35.7 ± 6.7 (0.693 ± 0.042) 
3.70 ± 0.52 (0.307 ±0.042) 
- 
N245T 
1142 ± 471 (0.409 ± 0.096) 
43.4 ± 18.9 (0.293 ± 0.090) 
3.59 ± 0.83 (0.298 ± 0.055) 
12.8 ± 2.6 (0.311 ± 0.061) 
3.09 ± 0.68 (0.689 ± 0.061) 
5.98 ± 2.68 (0.251 ± 0.157) 
1.42 ± 0.26 (0.748 ± 0.155) 
M246T 
368 ± 77 (0.589 ± 0.112) 
33.3 ± 3.9 (0.172 ± 0.005) 
3.30 ± 2.44 (0.239 ± 0.117) 
15.7 ± 5.9 (0.404 ± 0.193) 
1.30 ± 0.37 (0.596 ± 0.193) 
5.94 ± 1.65 (0.307 ± 0.107) 
1.15 ± 0.18 (0.693 ± 0.104) 
D247T 
878 ± 8 (0.425 ± 0.048) 
238 ± 30 (0.382 ± 0.026) 
17.5 ± 10.5 (0.193 ± 0.036) 
40.7 ± 16.2 (0.387 ± 0.126) 
8.81 ± 3.58 (0.613 ± 0.126) 
1.71 ± 0.14 
A248T 
1439 ± 751 (0.500 ± 0.081) 
69.1 ± 20.1 (0.305 ± 0.117) 
6.25 ± 2.5 (0.194 ± 0.062) 
9.78 ± 1.86 (0.419 ± 0.065) 
2.77 ± 0.90 (0.581 ± 0.065) 
3.52 ± 0.46 (0.492 ± 0.027) 
0.098 ± 0.017 (0.508 ± 
0.033) 
A249T 
6991 ± 4546 (0.546 ± 
0.060) 
46 ± 1.4 (0.154 ±0.037) 
4.23 ± 0.47 (0.300 ± 0.031) 
51.7 ± 4.4 (0.795 ±0.031) 
13.1 ± 3.5 (0.205 ± 0.031) 
2.40 ± 0.49 (0.505 ± 0.049) 
0.114 ± 0.029 (0.495 ± 
0.052) 
a
 This construct expressed poorly, complicating kinetic measurements 
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Some factors that can lead to variability in the rate of entry into desensitization have been previously 
described. For example, for the muscle AChR, it has shown that the phosphorylation of serines (Huganir 
et al., 1986; Safran et al., 1987; Schroeder et al., 1991) and a tyrosine (Wagner et al., 1991; Hopfield et 
al., 1988) in the M3-M4 loop of the δ subunit, as well as a tyrosine in the M3-M4 loop of the β1 subunit 
(Wagner et al., 1991; Paradiso and Brehm, 1998), alters the kinetics associated with desensitization. 
Thus, variation in the phosphorylation state of receptors is one potential culprit. Unfortunately, the 
complexity of interactions between AChRs and their environment, combined with the strong possibility 
that there are many such interactions that remain unknown, hinders our ability to accurately ascribe the 
variability to any single factor.  
4.3.3 GlyR M1-M2 scanning mutagenesis 
To determine whether mutations to the M1-M2 loop have similar effects throughout the Cys-loop 
superfamily, threonine and alanine scanning mutations were engineered in the M1-M2 loop of the 
human α1 GlyRs, which were then assayed in fast-perfused outside-out patches. Results of these scans, 
presented in Table 4.4, show that there are no remarkable kinetic differences between wild-type and 
mutant constructs for the rates of deactivation and entry into desensitization. A graphical comparison 
shows that the M1-M2 linker 
mutant constructs typically 
exhibited wild-type-like recovery 
from desensitization (Figure 4.7). 
It had been previously reported 
that a naturally occurring 
hyperekplexia mutation causes 
changes in the kinetics associated 
with desensitization (Saul et al., 
1997). While this construct 
unfortunately did not express in 
our experience, based on the rest 
of our M1-M2 mutagenesis data, 
we speculate that the rates of 
entry into and recovery from 
desensitization are unlikely to be 
Figure 4.7. The effect of scans of the M1-M2 linker on recovery 
from desensitization in the human α1 GlyR. A, Alanine and B, 
threonine scans were performed on the M1-M2 linker of the α1 
GlyR. Axes labels are the same for both panels. Plots were 
generated in the same way as for Figure 4.4. Because the number 
of components necessary to fit the data varied depending upon 
the mutant, it is not straightforward to compare rates across 
mutants. However, this graphical comparison shows that, for the 
most part, there is not much difference in the rate of recovery 
from desensitization across mutants, suggesting that mutations 
to the M1-M2 linker do not affect this parameter in the α1 GlyR. 
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affected much by the mutation; if this mutation leads to hyperekplexia, it seems more likely that it is 
through means other than kinetic alterations of GlyR behavior (a notion that has been previously 
proposed for other reasons; Breitinger and Becker, 2002). 
Overall, our ability to compare desensitization timecourses across constructs was marred by the very 
large patch-to-patch variability (even more pronounced than in the AChR). As previously reported 
(Papke et al., 2011), there is considerable variability both in the number of exponential components 
necessary to achieve a good fit and, when comparing traces well-fit with the same number of 
components, in the time constants for each component (Figure 4.8A). Based upon the aforementioned 
phosphorylation results for other Cys-loop superfamily members, we suspected that this variability 
might be due to cell-to-cell variation in the post-translational modifications of the M3-M4 loop. To 
address this possibility, we replaced the long M3-M4 loop of the α1 GlyR with the M3-M4 heptapeptide 
of the bacterial homolog GLIC (a construct hereafter referred to as the “GlyRM3M4”). As shown in Figure 
4.8B, replacement of the loop had no effect on the variability of the timecourses of entry into 
desensitization. Since the heptapeptide lacks any known sites of post-translational modification, we 
conclude that post-translational modulation of the M3-M4 loop cannot explain the variability seen in 
Figure 4.8. Heterogeneity of the GlyR timecourses of entry into desensitization. A, Responses from 
three different patches are shown. The blue and green traces required two exponential components to 
generate a good fit; however, the slow component of the blue trace was an order of magnitude larger 
than that of the green trace. The red trace required four components to achieve a good fit. The 
differences between these traces are indicative of the typical patch-to-patch variation seen with these 
receptors. B, Responses from three different GlyRM3M4-containing patches are shown. The red trace 
required three exponential components to achieve a good fit, while the blue trace required two and the 
green trace required one. The variability of this construct appears to be no different from that of the 
wild-type α1 GlyR. We conclude that the variable behavior of these receptors must be more than just a 
function of post-translational modifications of the M3-M4 loop. 
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these receptors. In other words, the variability of the entry into desensitization timecourse of the GlyR 
must stem from variability in regions of the protein other than the large cytosolic M3-M4 loop. 
Considering all of our GlyR results together, we conclude that any effects of intracellular loop 
modifications, including M1-M2 linker mutations, must be small relative to the normal variability seen 
with these receptors. 
4.3.4 GlyR desensitization timecourses and chloride depletion 
It was recently proposed that at least some of the variability in entry into desensitization timecourses is 
the result of an artifact introduced by the large ensemble currents passing through excised patches 
(Karlsson et al., 2011). The proposed idea was that, owing to the large flux of chloride ions through the 
membrane in excised patches in response to a long, saturating glycine pulse, the concentration of ions 
transiently changes, leading to a change in the driving force of chloride across the membrane. This 
Figure 4.9. Sharp component of GlyR desensitization timecourse not due to transient chloride loss. A, 
A long pulse of 10-mM Gly was delivered to an outside out patch of membrane pulled from cells 
transfected with cDNA for the α1 GlyR. The GlyRs in the membrane clearly exhibited a sharp component 
of desensitization. Initially, the transmembrane potential was clamped at –80 mV. After 0.9 s, the 
potential was switched to 0 mV for 1.8 s, and then switched back to –80 mV. If the sharp component 
were due to transient changes in the chloride gradient, the time spent at 0 mV would have been 
sufficiently long for chloride-gradient re-equilibration to occur, and, thus, we would expect a sharp 
component to appear upon switching potential from 0 mV to –80 mV. Since the sharp component did 
not reappear upon switching from 0 mV to –80 mV, we conclude that it is part of the desensitization 
timecourse, and not an artifact introduced by large currents. B, Recovery protocol for a patch that 
exhibited a sharp component. Significant recovery of the sharp component is seen after 1 s. We 
conclude that a 1.8-s interval without agonist in A is a long enough period of time to recover the sharp 
component. If sharp component recovery were only due to the lack of currents during the interpulse 
interval (i.e. in line with the chloride hypothesis), then we would expect it to be recovered during the 0-
mV period in A. 
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change in driving force purportedly gives rise to the very fast component of entry into desensitization 
seen in many Gly-evoked current traces. In other words, the sharp component of these timecourses is 
not desensitization at all, but is only an artifact introduced by a transient change in chloride 
concentration.  
To investigate this possibility, after achieving a patch with a sharp component, we applied 10-mM Gly at 
–80 mV, then switched the potential to 0 mV for a short time, and then switched back to –80 mV (Figure 
4.9A). At 0 mV, channels can still undergo kinetic transitions such as desensitization, but, with the ion 
conditions used for the experiment, there is no net flow of chloride ions across the membrane. Hence, 
were the sharp component truly desensitization, then, upon switching from 0 mV to –80 mV, we would 
not expect to see the sharp component, since the desensitization timecourse should be unaltered by the 
membrane potential changes. However, if the sharp component were an artifact of chloride depletion, 
then the time spent at 0 mV would allow partial recovery of the transient chloride loss, in which case we 
would expect to see the sharp component reappear (note that, based on our recovery protocols, a 1.8-s 
neurotransmitter-free interval would allow full recovery of the sharp component; Figure 4.9B). In Figure 
4.9A, we show that the sharp component does not reappear upon switching from 0 mV to –80 mV, 
implying that our timecourses of entry into desensitization are true reflections of desensitization, not 
artifacts of changing chloride ion gradients. Thus, the chloride depletion hypothesis does not appear to 
explain the sharp component seen in outside-out patches, and, as a result, it also does not explain the 
variability in the number of exponential components necessary to fit timecourses of entry into 
desensitization. 
This result leads to the question of what causes the large variability seen in the timecourses of entry into 
desensitization. It is known that changes in the lipid environment can lead to differences in the behavior 
of other Cys-loop family members, including the AChR (Fong and McNamee, 1986; daCosta and 
Baenziger, 2009) and the serotonin receptor (Nothdurfter et al., 2010). Hence, cell-to-cell variation in 
the prevalence of different lipid components could plausibly underlie the variability in kinetics of entry 
into desensitization in GlyRs. Also, it is known that members of the superfamily undergo extracellular 
modifications such as channel glycosylation (Sumikawa and Miledi, 1989). Alterations to N-glycosylation 
sites have been shown to affect AChR kinetics (Gehle et al., 1997), as have many known mutations to 
the extracellular domain (for example, Akk et al., 1996). Hence, extracellular modification plausibly 
could contribute to the cell-to-cell variation in GlyR desensitization timecourses. Finally, it is also 
conceivable that there is cell-to-cell variation in protein folding, leading to differences in the states 
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accessible to channels on a cell-to-cell basis. In the end, we do not know whether any of these factors is 
the culprit. We have, however, presented evidence that modifications of the M3-M4 loop are unlikely to 
underlie the extreme variability in the rate of entry into desensitization in GlyRs. 
4.4 Concluding remarks 
In this work, we have shown that kinetic behavior of the human α1 GlyR and human muscle AChR is 
largely unaffected by mutations to the M1-M2 linker, and that removal of the M3-M4 loop has no 
apparent effect on GlyR kinetics. Mutations to the M1-M2 linker inconsistently affect deactivation, and, 
when they have an effect, it is small compared the effect of mutations to pore-lining residues in the M2 
segment and residues in the M2-M3 linker. Furthermore, we uncovered a heretofore unappreciated 
aspect of the complexity of desensitization in the AChR – variability in the average receptor behavior 
over long periods of time (i.e. several months); from this work, we conclude that, to determine the 
effect of a mutation on the timecourse of entry into desensitization, it is necessary to run both 
experimental and control experiments in the same day. Finally, we conclude that the variability in the 
timecourse of desensitization for the GlyRs is not due to post-translational modification of the M3-M4 
loop, nor is it the result of an artifact introduced by large chloride currents. 
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Appendix – Physiology News Review  
Is the desensitization of postsynaptic receptor-channels relevant?  
Our brains have many trillions of chemical synapses (Pakkenberg et al., 2003). During fast synaptic 
transmission, presynaptic terminals emit series of brief neurotransmitter pulses that are sensed by 
neurotransmitter-gated ion channels (NGICs) located in the postsynaptic cell membrane. NGICs have 
both an extracellular neurotransmitter-binding domain and a transmembrane pore that can alternately 
adopt ion-conductive (“open”) and non-conductive (“closed” and “desensitized”) conformations. The 
binding of neurotransmitter favors the open conformation of the pore over the closed, and thus allows 
ions to pass through the channel and change the electrical potential across the membrane. The 
magnitude of this change in membrane voltage can decrease with each successive puff, or “pulse,” of 
neurotransmitter despite constant stimulation of the presynaptic neuron, a phenomenon termed 
“short-term synaptic depression” (Figure A.1). This depression can affect signal transmission because, 
for an action potential to be propagated to the next cell, the change in the postsynaptic membrane 
potential needs to surpass a threshold. Indeed, if the postsynaptic response declines enough during the 
course of a series, or “train,” of neurotransmitter pulses, this threshold will not be overcome, and the 
propagation of the signal will be prevented. Short-term synaptic depression has been observed in 
synapses in the brain, but there is still uncertainty surrounding the causes. In fact, several distinct 
mechanisms have been proposed to underlie this phenomenon. 
In our work, we have examined one such mechanism, namely, the progressive loss of receptor 
responsiveness over the course of a series of neurotransmitter pulses resulting from the receptors 
entering the “desensitized” state. Like the closed conformation of the channel, the desensitized 
conformation is non-conductive. Unlike the closed conformation, however, the desensitized state of 
neurotransmitter-bound receptors is very stable, and thus, desensitized channels do not open readily. 
The physiological role of this refractory conformation has been a long-standing mystery in the field of 
ion-channel research. Out of the three superfamilies of NGICs – excitatory glutamate receptors, Cys-loop 
receptors and purinergic receptors, altogether comprising several dozens of channels – every known 
channel can desensitize upon binding neurotransmitter. Indeed, applying a sufficiently long pulse of 
neurotransmitter to a group of receptors will force essentially all of them into the desensitized state. 
However, in the body, neurotransmitter pulses are generally too short (the average duration is thought 
to be in the 100-µs to 1-ms range) for a large fraction of the channels to desensitize during the pulse. So, 
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in spite of its conservation among NGICs, the desensitized state has historically been deemed 
physiologically irrelevant [with the AMPA-type glutamate receptors (AMPARs) being, perhaps, the best-
studied exception; Trussell and Fischbach, 1989]. Hence, researchers studying synaptic depression have 
focused on other mechanisms of controlling signal transmission in synapses, while giving desensitization 
relatively little consideration. 
 
Work from a number of laboratories has shown that desensitization can affect the response of AMPARs 
and muscle acetylcholine receptors (AChRs) to synaptic-like stimulation in excised pieces of membrane 
(known as “outside-out patches”). In the case of the fast-desensitizing AMPARs, some desensitization is 
Figure A.1. Peak-current 
depression upon repetitive 
stimulation. A–G, Current traces 
recorded from individual 
outside-out patches. Each panel 
is the response of a different 
NGIC to the application of a 50-
Hz train of 1-ms pulses of 
saturating neurotransmitter for 
2 s. One such train is indicated in 
A above the current trace. The 
zero-current level is indicated 
with a dotted line. The 
concentration of 
neurotransmitter was 1-mM 
ACh, 10-mM GABA, 10-mM Gly, 
10-mM Glu and 0.85 mM-ATP 
for the AChR, the GABAAR, the 
GlyRs, the AMPARs and the 
P2X2R, respectively. Although 
the responses recorded from 
individual patches exhibited high 
patch-to-patch variability, the 
traces shown are representative 
of the average behavior of each 
receptor.  
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expected to occur during brief glutamate pulses. However, it has been shown that desensitization during 
the pulses cannot account for the amount of depression that is seen in response to repetitive 
stimulation (Raman and Trussell, 1995). Recently, it has been shown that desensitization of AMPARs is 
critically important for brain function – a mutation that impairs desensitization is lethal in mice (Christie 
et al., 2010). These results beg further investigation into the role of desensitization in synaptic responses 
mediated by these fast-desensitizing channels. 
 
But what about slower-desensitizing receptors? As it turns out, significant peak response depression 
occurs when outside-out patches containing AChRs are subjected to repetitive stimulation. By examining 
the effect of both lab-generated and naturally-occurring mutations, Elenes and coworkers (2006, 2009) 
reported that AChRs desensitize during repetitive stimulation despite the short (1 millisecond) duration 
Figure A.2. Desensitization occurs 
mostly during the interpulse 
intervals. A, Response of an 
outside-out patch containing GluA1 
AMPARs to the application of a 50-
Hz train of 1-ms pulses of 10-mM 
Glu magnified so as to show only 
the first two current transients. The 
zero-current level is indicated with a 
black dotted line. The red dotted 
lines help distinguish the extent to 
which desensitization occurs during 
the 1-ms application of Glu (blue 
arrow) from that occurring in 
between applications (green arrow), 
assuming negligible desensitization 
during the rising phase of the 
response. Because desensitized 
receptors can recover during the 
interpulse intervals, the extent of 
desensitization is actually larger 
than that indicated by the green 
arrow. B, Response of an outside-
out patch containing GABAARs to 
the application of a 50-Hz train of 1-
ms pulses of 10-mM GABA. As in A, 
only the first two current transients 
are shown. Note that the extent of 
desensitization during the 1-ms 
pulse of GABA is negligible. 
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of each individual pulse. In this work, it was found that mutant AChRs with prolonged deactivation 
timecourses (that is, longer “bursts” of single-channel openings, on average) exhibit more peak-
response depression over the course of a train of pulses than wild-type receptors. This finding is 
consistent with the idea that receptors are prone to desensitize during the neurotransmitter-free 
interpulse intervals, while neurotransmitter dissociates from the receptor’s binding sites. Of course, 
during this time, NGICs are “unaware” of the loss of external neurotransmitter as long as their binding 
sites remain occupied, and so they still can desensitize. Therefore, the ability of receptors to desensitize 
during physiological stimulation is not limited by the duration of neurotransmitter pulses (see Figure 
A.2). 
In our recent work (Papke et al., 2011), we investigated whether the conclusions from work with 
AMPARs and AChRs can be generalized to all NGICs. To this end, we examined all types of receptors 
known to be involved in fast neurotransmission – P2X2 receptors from the purinergic receptor 
superfamily, AMPARs from the excitatory glutamate receptor superfamily, and glycine, GABAA, and ACh 
receptors from the Cys-loop superfamily. Upon exposing these receptors to series of brief pulses at 50 
Hz (a high, but physiologically relevant frequency), we observed a decline in the peak responses in every 
case (Figure A.1). Clearly, desensitization can affect the responses of all NGICs, not just the fast-
desensitizing ones. 
In order to put these results into a broader context, we need to consider another kinetic property of 
these receptors: recovery from desensitization. Desensitized, ligand-bound NGICs can “recover” from 
this refractory state by returning to the closed, unliganded conformation. But recovery typically takes 
quite a long time, roughly on the order of hundreds of milliseconds. As the frequency of stimulation 
decreases, receptors have increasingly more time to recover between pulses, and as a result, there is 
less depression in the peak responses to stimulation (Figure A.3). Depending on the threshold for signal 
propagation, it is conceivable that receptors could prevent high-frequency signal transmission while 
allowing low frequency signals to pass through; for example, in Figure A.3E, if the threshold were at half 
the maximal peak amplitude, then a 10-Hz signal would be propagated while a 25-Hz signal would not. 
Therefore, it is possible that receptor desensitization allows synapses to act as low-pass filters. Low-pass 
filtering behavior has been described in some synapses (Fortune and Rose, 2001), although the extent to 
which receptor desensitization contributes to this phenomenon remains to be determined. 
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Figure A.3. Frequency dependence 
of depression. Normalized peak 
responses to trains of 
neurotransmitter pulses delivered at 
different physiologically-relevant 
frequencies. Error bars are standard 
errors. The point corresponding to 
the first pulse in each train (black 
symbol) is the same for all trains. 
The colour code is: 1 Hz, blue; 5 Hz, 
purple; 10 Hz, green; 25 Hz, cyan; 
and 50 Hz, red. The concentration of 
each neurotransmitter was as 
indicated for Fig. A.1. 
 
 
Our results may superficially seem to contradict the finding that high frequency signals can pass through 
some synapses apparently unhindered by desensitization. However, these synapses could be structurally 
adapted to circumvent the limitations imposed by receptor desensitization through, for example, the 
use of multiple release sites with low release probabilities (note that such a system would be defined as 
multiple synapses by some researchers; Stevens, 2003b). By having many such low-probability release 
sites, a synapse may succeed in repeatedly surpassing the postsynaptic threshold potential, even at high 
frequencies, because each individual receptor would be activated at only a fraction of the frequency of 
the incoming train of action potentials. Alternatively, a sufficiently low threshold for signal propagation 
might permit signals to pass despite a strong decline in NGIC responsiveness. 
What we now know, through our work and the work of others, is that NGICs desensitize in response to 
brief pulses, and that, if a given set of such receptors were exposed to repetitive stimulation at 
physiological frequencies, then desensitization would lead to the progressive decrease of peak-current 
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amplitudes. Along with the better-known presynaptic mechanisms, receptor desensitization could 
conceivably provide yet another variable for the synaptic control of signal propagation. 
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